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Summary  
Burkholderia pseudomallei, the etiological agent of melioidosis, is a Gram-negative 
bacterium. In this thesis, for the first time, the lipopolysaccharide (LPS) of 
B. pseudomallei was characterised and compared to that of B. thailandensis, a close 
relative of B. pseudomallei that rarely causes disease, to uncover important virulence 
mechanisms that may contribute to B. pseudomallei s pathogenesis.   
Initial fatty acid (FA) compositional analysis revealed that the LPS of B. pseudomallei 
differed from that of B. thailandensis, by the presence of 2-hydroxy-tetradecanoic acid 
[C14:0(2-OH)]. Similarly, in-vitro experiments indicated that B. thailandensis LPS 
induced two times higher levels of cytokine production in murine macrophages than 
B. pseudomallei LPS. The LPS of B. pseudomallei and B. thailandensis were also found 
to activate immune cells through Toll-like Receptor 4 (TLR4). The presence of 
contaminating proteins in extracted LPS is likely to be responsible for the observation by 
other groups that TLR2 is the pattern recognition receptor of B. pseudomallei LPS.    
As the structure of the lipid A moiety has been described to influence its biological 
activity, the lipid A from B. pseudomallei was subjected to further structural 
characterization by mass spectrometry, and compared to that of B. thailandensis to 
identify unique features that contribute to the differences in biological activity observed 
in-vitro. The major lipid A species identified in B. pseudomallei consisted of a 
bi-phosphorylated disaccharide backbone modified with 4-amino-4-deoxy-arabinose 
 x
(Ara4N) at both phosphate groups and penta-acylated with FA 3-hydroxy-tetradecanoic 
acid [C14:0(3-OH)], 3-hydroxy-hexadecanoic acid [C16:0(3-OH)] and either 
tetradecanoic acid (C14:0) or C14:0(2-OH). The major lipid A species identified in 
B. thailandensis had a similar architecture with some essential differences. These include 
lipid A species without C14:0(2-OH) and major lipid A species with only one or none of 
the phosphate groups modified with Ara4N. These unique features may be responsible 
for the differences in the ability of the two pathogens to activate murine macrophages 
in-vitro and may play an important role in the pathogenesis of the pathogen by allowing 
B. pseudomallei to evade the innate immune system and survive intracellularly. Further 
studies are required to confirm these suggestions.  
Some Gram-negative bacteria, such as Salmonella enterica serovar Typhimurium modify 
their lipid A structure when cultured in low magnesium medium, an environment that 
mimics the macrophage phagosomal environment. Here, the effect of low magnesium 
culture medium on the LPS of B. pseudomallei was investigated. However, no changes 
were observed in both FA composition and cytokine induction in in-vitro stimulation 
assays with LPS extracted from B. pseudomallei cultured in magnesium supplemented or 
magnesium minimal medium. The LPS of Salmonella serovar Typhimurium was 
similarly extracted from magnesium supplemented or magnesium minimal medium and 
as shown in literature, changes were observed in both FA composition and cytokine 
induction. Taken together, the data in this thesis suggest that B. pseudomallei LPS is able 
to evade innate immune activation and does not require external stimulus to alter its 
structure.  
 xi
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1.1 INTRODUCTION  
Burkholderia pseudomallei, formerly known as Pseudomonas pseudomallei 
(Yabuuchi et al., 1992), is a Gram-negative bacterium that was first identified by 
Whitmore in 1911 (Miller et al., 1948). It is the etiological agent of melioidosis, an 
infectious disease of major public health importance in southeast Asia and northern 
Australia (Cheng and Currie, 2005).   
Over the past 5 years, basic research on this pathogen has progressed rapidly. This is 
partly due to the increased recognition of the organism, with the discovery of sporadic 
cases outside endemic areas, the fear that the bacterium may be used as a biological 
weapon and the availability of genomic sequence data that facilitated the 
identification of virulence factors (Vietri and DeShazer, 2007).  
The fatality rate of melioidosis remains high in endemic countries despite the 
availability of intensive treatment with appropriate antibiotics (Woods et al., 1999). 
The time between acquisition and the onset of melioidosis is reported to vary from 2 
days in acute disease to 62 years in sub-clinical, chronic or relapse cases 
(Leelarasamee and Bovornkitti, 1989; Mays and Ricketts, 1975; Ngauy et al., 2005). 
As B. pseudomallei is a facultative intracellular pathogen, many groups have 
postulated that after the initial phase of infection, the bacterium may exist in a 
dormant stage in macrophages for months and years (Vietri and DeShazer, 2007). 
This, and the ability of B. pseudomallei to escape the innate immune response and 
appear inconspicuous to the host immune system may be responsible for the long 
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latency period (Brett et al., 2000; Stevens et al., 2004; Woods et al., 1999) in 
melioidosis.  
One mechanism used by B. pseudomallei to evade host detection is the weak 
activation of the innate immune system (Utaisinchroen et al., 2001). This may be in 
part due to the synthesis of lipopolysaccharide (LPS) molecules of weak activity 
in-vitro (Matsuura et al., 1996; Utaisinchroen et al., 2000). Since unique structural 
features in the LPS of some Gram-negative bacteria have been shown to be 
responsible for intracellular survival (Ernst et al., 2003; Guo et al., 1997), LPS may 
similarly play an important role in the intracellular survival of B. pseudomallei. This 
literature review will look into the background of melioidosis and the role of LPS in 
the pathogenesis of this bacterium.       
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1.2 MELIOIDOSIS  
1.2.1 Distribution 
Melioidosis is predominantly a disease of tropical climates, especially in southeast 
Asia and northern Australia where it is endemic (Cheng and Currie, 2005; 
Dance, 1991, 2000; Dharakul and Songsivilai, 1999). In northeast Thailand, 
melioidosis accounts for 20% of community acquired septicaemia (Chaowagul et al., 
1989), and is responsible for 40% of sepsis related deaths (White et al., 2003). The 
annual incidence in Ubon Ratchathani province in northeast Thailand was 4.4 cases 
per 100,000 between 1987 and 1991 (Suputtamongkol et al., 1994). Sporadic cases 
have been reported throughout the world, including Africa (Dance, 1991), the Middle 
East (Pourtaghva et al., 1977), the Caribbean and Central and South America (Inglis 
et al., 2006; Rolim et al., 2005).  The number of cases around the world has 
significantly increased with melioidosis becoming endemic in New Caledonia 
(Le Hello et al., 2005) and following the Asian Tsunami (Cierakul et al., 2005; 
Nieminen and Vaara, 2005).   
In Singapore, the first case of melioidosis was reported in 1920, but it was not 
recognized as an important health threat until three fatal septicaemic cases among 
healthy young adults were reported in 1989. Since this incident in 1989, melioidosis 
was made administratively notifiable to the Ministry of Health (Ministry of Health, 
2004b), and in December 2008, this was upgraded to legally notifiable for disease 
surveillance. Between 1990 and 2006, an average of 63 cases was reported each year 
with an annual case fatality rate of 25.9%. The incidence rate was 1.3 per 100,000 
population in 2006 (Ministry of Health, 2006). In 2004, between January and July, a 
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higher number of cases, 58 compared to 13 and 14 cases during the same period in 
2002 and 2003, respectively were notified to the Ministry of Health, with a case 
fatality rate of 40% (Ministry of Health, 2004b). This peak of cases coincided with the 
heavy rainfall (Ministry of Health, 2004c) experienced during that period and no 
common source was found between the different infections (Liu et al., 2006).  
1.2.2 Acquistion of disease 
Melioidosis is a disease often reported in individuals who have been exposed to 
environments containing B. pseudomallei (Wiersinga et al., 2006). However, one case 
of perinatal transmission of melioidosis from mother to baby has been described after 
a vacation in Thailand (Abbink et al., 2001). The precise mode of acquisition of 
melioidosis is unknown but majority of melioidosis infections are assumed to result 
from percutaneous inoculation through open cuts. In Thailand, where the highest rates 
of melioidosis are described, exposure occurs very frequently during rice farming, 
which is the main occupation in the region (White, 2003). The farmers rarely wear 
protective footwear and their feet often show signs of repeated trauma and injuries 
(Wiersinga et al., 2006). Serological studies have shown that in Thailand, exposure 
arises as soon as the infant makes contact with soil and water and 25% of children 
seroconvert every year for the first 4 years of life (Kanaphun et al., 1993). Of the total 
melioidosis cases notified between March to April 2004 in Singapore, 61% had 
significant exposure to soil (construction workers and outdoor sports), suggesting 
inoculation as an important mode of infection (Ministry of Health, 2004a).  
Inhalation has also been postulated to be an important mode of disease acquisition. 
This is partly due to the strong association of melioidosis cases with the monsoonal 
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rainy season in endemic countries (Chaowagul et al., 1989; White, 2003). Aerosols 
created during heavy rain results in inhalation of the organism, shifting the primary 
mode of acquisition from cutaneous inoculation to inhalation (Currie et al., 2003). 
Further, higher rainfall is significantly associated with pneumonia.  The higher case 
fatality observed in Singapore during the first seven months in 2004 was strongly 
correlated to the higher rainfall experienced during that period.  A higher proportion 
of patients presented with pneumonic form of disease; 73.1% compared to 36.4% in 
the same period, the year before, was also observed (Ministry of Health, 2004c). 
During the Vietnam war, a fairly high incidence of melioidosis was reported among 
helicopter crew (Howe et al., 1971). It has been postulated that the rotor blades of the 
helicopters probably produced aerosols from the wet paddy fields, hence spreading 
the disease to the soldiers via inhalation.  
More recently, involvement in the 2004 tsunami has been described as a major risk 
factor for melioidosis (Chierakul et al., 2005). Ingestion may also pose as a mode of 
infection (Cheng and Currie, 2005) as contamination of potable water had been 
implicated in a cluster of cases in Northern Australia (Currie et al., 2001).   
Presence of underlying disease is a well-recognised risk factor for melioidosis. These 
include diabetes mellitus, renal failure, alcohol excess, chronic lung disease and low 
immune status (Cheng and Currie, 2005; White, 2003).  Incidence of melioidosis 
cases peaks between the fourth and sixth decade of life in Thailand, with more than 
80% of the adults having one or more underlying diseases (Wiersinga et al., 2006). A 
population-based study in Australia found higher risk of melioidosis among those 
aged more than 45 years, diabetics or those with excess alcohol consumption, chronic 
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lung disease, and chronic renal disease (Cheng and Currie, 2005). In Singapore, the 
highest incidence rate was observed among adults aged 65 and above (5.4 per 
100,000) (Ministry of Health, 2006). Higher mortality rates were also observed 
among those with co-morbidities (Ministry of Health, 2006). Among the 62 cases 
reported in 2006, 86.4% had co-morbidities (Ministry of Health, 2006). The most 
common was pneumonia (55.9%), followed by diabetes mellitus (52.5%) and 
hypertension (30.5%).   
1.2.3 Clinical presentation and treatment 
Infection with melioidosis occurs primarily in three clinical forms: Asymptomatic, 
localised infection, or septicaemia (Wiersinga et al., 2006). The clinical symptoms of 
melioidosis mimic those of many other diseases and thus differentiating melioidosis 
from other acute and chronic bacterial infections is difficult without laboratory tests 
(Peacock, 2006). Confirmation of melioidosis requires laboratory culture and isolation 
of B. pseudomallei, which is not readily available in many hospitals in endemic 
regions. Infection with B. pseudomallei may be clinically silent for many years after 
exposure, and the development of disease usually occur as a result of a change in 
immune status (Woods et al., 1999).   
The most severe clinical manifestation in melioidosis is septic shock, which is often 
associated with pneumonia and bacterial dissemination to distinct sites (Wiersinga et 
al., 2006) Other clinical presentations include genitourinary infection, 
encephalomyelitis, liver and spleen abscesses, neurological or brain abscesses, and 
skin or soft tissue infection (Cheng and Currie, 2005).   
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Currently, no effective method of prevention of melioidosis exists (Leelarasamee et 
al., 2004). There is no vaccine against B. pseudomallei and the bacterium is 
intrinsically resistant to penicillin and gentamicin, the usual treatment for suspected 
septicaemia in many parts of the developing world where melioidosis is endemic 
(Brett et al., 2000). Even under the best circumstances, prolonged treatment with 
expensive antibiotics is required for the eradication of this organism, although relapse 
is common. The current treatment of choice are parenteral ceftazidime for ten to 
fourteen days or longer as clinically indicated, followed by oral TMP-SMX with 
doxycycline for at least twelve to twenty weeks (Wuthiekanun et al., 2006).   
Recurrent melioidosis is an important cause of morbidity and mortality in patients 
who survive a primary infection. The rate of relapse is approximately 6% in the first 
year and 13% during the next 10 years of follow up (Peacock, 2006). Among relapse 
patients, 75% were caused by re-infection with the same strain. This could be a result 
of failure in antibiotic treatment or that the primary infection was caused by more than 
one strain of the bacterium (Peacock, 2006). One study suggested that the failure to 
complete at least 12 weeks of therapy was an important determinant of relapse, 
reinforcing the necessity for adherence to therapy (Cheng and Currie, 2005). 
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1.3 BURKHOLDERIA PSEUDOMALLEI  
1.3.1  Environmental niche 
Burkholderia pseudomallei is a soil saprophyte, and can be recovered readily from 
water and wet soils in endemic areas (White et al., 2003). B. pseudomallei is able to 
survive hostile environmental conditions such as nutrient deficiency, acidic 
environments and dehydration (Cheng and Currie 2005; Inglis and Sagripanti  2006). 
Interestingly, B. pseudomallei has been shown to survive in sterile triple distilled 
water for more than 17 years in a non-replicative state (Wuthiekanun et al., 1995; 
Moore et al., 2008). Based on these observations, it has been suggested that the 
increase in B. pseudomallei infection observed during the rainy season may partly be 
due to the switching of the bacteria from a dormant and non-culturable state to a more 
replicative state (Currie, 2008).   
1.3.2  Military relevance 
B. pseudomallei is currently classified as a category B bioterrorism agent by the US 
Centers for Disease Control and Prevention, because of the ease of dissemination, and 
the ability to result in moderate morbidity and low mortality rates due to the lack of 
appropriate treatment. This pathogen has been studied by the United States, the 
former Soviet Union and possibly Egypt as a potential biological warfare weapon, 
although they have never been used in this capacity (Vietri and DeShazer, 2007). The 
use of B. pseudomallei as a possible biological warfare agent is a serious concern due 
to the ease of acquiring strains from the environment and the lack of a vaccine.   
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1.3.3 Intracellular survival 
An important aspect of interaction with host cells is the ability of B. pseudomallei to 
survive intracellularly in both phagocytic and non-phagocytic cells (Egan et al., 1996; 
Jones et al., 1996; Wiersinga et al., 2006). Upon internalization, B. pseudomallei may 
either reside within the acidic environment of phagolysosomes, or escape into the 
cytoplasm (Stevens et al., 2002). Within the cytoplasm it induces the formation of 
actin associated membrane protrusions, which facilitates cell-to-cell spread and the 
formation of multinucleated giant cells (MNGC) (Kespichayawattana et al., 2000). 
MNGC has been identified in tissues of melioidosis patients and it is has been 
suggested that the formation of such fused cells sequesters the pathogen and shields it 
from host surveillance (Wong et al., 1995).   
Intracellular survival of B. pseudomallei may play an important role in evading the 
host system (Brett et al., 2000; Stevens et al., 2004; Woods et al., 1999). In-vitro 
models indicate that B. pseudomallei uses multiple mechanisms to survive 
intracellularly. These include its type III secretion system (TTSS) and capsular 
polysaccharide. Cluster three of TTSS (TTSS3) was required for full virulence of 
B. pseudomallei in a hamster model of infection (Warawa et al., 2005). TTSS3 in 
B. pseudomallei (termed bsa, Burkholderia secretion apparatus) shares homology 
with the inv/spa/prg TTSS of Salmonella enterica serovar Typhimurium, which is 
required for the invasion and survival of this pathogen within host cells.  The bsa 
cluster in B. pseudomallei has similarly been demonstrated to be required for its 
intracellular survival. Mutants lacking components of bsa show reduced invasion, 
replication in murine macrophages and inability to escape from endocytic vacuoles 
(Stevens et al., 2002).  For example, BopE and BipD secreted via the Bsa type III 
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apparatus were required for bacterial entry into HeLa cells. Furthermore, 
B. pseudomallei BipD mutants were attenuated following infection of mice, and 
showed impaired bacterial replication in liver and spleen (Stevens et al., 2002).   
B. pseudomallei produces an extracellular capsular polysaccharide. The presence of 
capsule may play an important role in its intracellular survival as phagocytosis was 
shown to be greater in capsule deficient mutant than wild type (Reckseidler-Zenteno 
et al., 2005). It has been described that the capsule may act as a barrier, shielding the 
organism from the host. This is based on the observation that deposition of 
complement factor 3b by host cells was lower in the presence of capsule.  
The ability of B. pseudomallei to survive intracellularly may partly be due to its 
resistance to antimicrobial activity and ability to evade macrophage killing. In-vitro, 
B. pseudomallei is resistant to the cationic antimicrobial peptide, human defensin and 
protamine sulfate (Jones et al., 1996). It has also been observed that B. pseudomallei 
inhibits DNA and protein synthesis in host cells (Mohamed et al., 1989). The exact 
mechanisms by which B. pseudomallei evades macrophage killing are unknown. 
However, upon invasion of macrophages, B. pseudomallei failed to substantially 
activate inducible nitric oxide synthase (iNOS), which plays an important role in the 
killing of intracellular bacteria (Utaisincharoen et al., 2001). The failure to activate 
iNOS may result from the inability to activate IFN- , which is an upstream activator 
of iNOS. Addition of exogenous IFN- was demonstrated to restore the macrophage 
ability to activate iNOS expression and consequently resulted in enhanced killing of 
the pathogen (Utaisincharoen et al., 2004). 
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1.4 LIPOPOLYSACCHARIDE (LPS)  
1.4.1 General architecture 
LPS is the outer membrane molecule found in Gram-negative bacteria. It consists of a 
hydrophobic domain termed lipid A, a non-repeating core oligosaccharide region, and 
a distal polysaccharide termed O-specific antigen that is the outermost region of LPS 
(Raetz et al., 2002).  Generally, two forms of LPS exist. The S-form (smooth) LPS 
consists of all the 3 segments of LPS and is so called due to the appearance of glossy 
and shiny colonies. The R-form (rough) of LPS consists of only lipid A and the core 
region, and gives rise to dull colonies. The presence of Lipid A and Kdo (anchor to 
core) is the minimal requirement for the growth of Gram-negative bacterium (Caroff 
et al., 2002). The additional core and O-specific antigen are not required for growth, 
but may help the bacteria resist the effects of antibiotics, the complement system and 
other environmental stress.  
1.4.2 Lipid A 
Lipid A is the most conserved region of LPS. It is the bio-active centre (Dixon et al., 
2005) and endotoxic component of the LPS, and the only region of the LPS that is 
recognised by the innate immune system (Miller et al., 2005).  The innate immune 
system is the first line of defence that recognises evolutionarily conserved patterns 
associated with pathogens such as LPS. It is able to detect pico-molar concentrations 
of LPS and trigger cellular response (Jerala, 2007). LPS is responsible for several 
symptoms and signs of sepsis such as fever, diarrhoea, hypotension and shock. The 
classical lipid A structure is represented by the LPS from Escherichia coli and 
 12
consists of a biphosphorylated disaccharide backbone acylated with hydroxy and 
non-hydroxy fatty acids at specific positions (Caroff et al., 2003).   
1.4.3 Activation of host cells by LPS (lipid A) 
The LPS receptor complex in host cells is made up of Toll-like receptor 4 (TLR4), 
MD2 and CD14. Lipid A is first recognised by the LPS binding protein (LBP), which 
transfers monomers of LPS to CD14. CD14 is a high affinity LPS receptor but does 
not have a cytoplasmic domain, and hence cannot transduce signal upon binding to 
LPS (Chow et al., 1999). Instead, CD14 concentrates LPS and transfers it to 
TLR4-MD2, which then initiates a complex signal transduction across the plasma 
membrane, ultimately leading to the activation of nuclear factor kappa beta (NF- ), 
with subsequent transcription and release of pro-inflammatory mediators including 
interleukin-1 (IL-1), interleukin-6 (IL-6), interleukin-8 (IL-8) and tumour necrosis 
factor alpha (TNF- ). LPS can bind directly to the TLR4/MD2 complex without LBP 
and CD14, although with lower affinity (Miyake et al., 2006).  There are 2 proposed 
signalling pathways after TLR4 activation, the MyD88 dependent pathway and 
independent pathways (Zughaier et al., 2005). In the MyD88 dependent pathway, 
there is rapid NF- activation and release of pro-inflammatory cytokines and 
chemokines. On the other hand, LPS activation of the MyD88 independent pathway 
leads to IFN- release and delayed NF- activation. This pathway appears to be 
important for dendritic cell maturation and is a link between the innate and adaptive 
immune response (Hoebe et al., 2003).   
Although lipid A was once thought to be a conserved molecule, it is diverse in both 
number and length of fatty acid side chains and other associated modifications. These 
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variations results in altered recognition of the molecule by TLR4. The hexa-acylated 
lipid A of E. coli with side chains of 12 to 14 carbons, has been shown to be 
maximally stimulating (Caroff et al., 2003). Any deviation from this structure such as 
the number or length of fatty acyl chains would reduce the magnitude of signal 
(Caroff et al., 2003; Raetz et al., 2002). An E. coli strain that was genetically 
modified to express penta-acylated lipid A showed reduced immunogenicity and acted 
antagonistically by also inhibiting pro-inflammatory signalling by wild-type E. coli 
and LPS from other bacteria (Backhed et al., 2003). Ernst et al., (2003) also 
demonstrated that LPS preparations from Pseudomonas aeruginosa clinical isolates 
expressing penta and hexa-acylated species stimulated more robust pro-inflammatory 
responses than LPS purified from clinical isolates expressing only penta-acylated 
species.  
The capacity of lipid A to stimulate host cells and induce cytokine production is 
dependent not only on the number and nature of fatty acids but also on the species of 
the host cells. Tanamoto and coworkers showed that chemically synthesized E. coli 
type hexa-acylated lipid A (compound 506) and Salmonella type hepta-acylated 
lipid A (compound 516) were able to strongly induce TNF- release in mouse 
peritoneal macrophages and mouse macrophage like cell-line J774-1 (Tanamoto and 
Azumi, 2000). However, in the human cell-lines THP-1 and U937, compound 516 
was completely inactive while compound 506 displayed strong activity. These results 
suggests that the mechanism of activation by LPS or the recognition of lipid A 
structure by human cells may differ from that in mouse cells.   
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Several groups have shown that the shape of lipid A may influence its biological 
activity and consequently the receptors that are activated (Netea et al., 2002; Seydel et 
al., 2000). The hexa-acylated shape of lipid A from E. coli assumes a conical shape 
and when intercalated into the membrane, induces a mechanical stress onto putative 
signalling proteins and signals through TLR4.  Porphyromonas gingivalis, which 
assumes a conical shape to a lesser degree stimulates through TLR2 (Netea et al., 
2002). On the other hand, lipid A from Chromobacterium violaceum that assumes a 
cylindrical shape would instead act antagonistically by occupying the binding site but 
not exerting the necessary stress for activation (Seydel et al., 2000) (Figure 1.1).  
1.4.4  Modification of lipid A structures 
For many pathogens, early innate responses slow the progress of infection, allowing 
the adaptive immune response to develop. Some Gram-negative bacteria have evolved 
mechanisms to modify their lipid A structures in different environments. This 
manipulates the pattern recognition motif used by the innate immune system to delay, 
evade or eliminate host recognition, hence subverting host immune response. Changes 
in acylation pattern and the modification of phosphate groups with 4-amino-4deoxy-
arabinose (Ara4N) are two common mechanisms used to modify the lipid A 
structures.  
In Salmonella enterica serovar Typhimurium, modification of lipid A occurs via the 
activation of a two component regulatory system PhoP-PhoQ (García Véscovi et al., 
1996). PhoQ is a sensor kinase that senses the different environmental conditions such 
as that inside a macrophage phagosome, or those that destabilise the bacterial 
membrane, such as magnesium limited growth medium and exposure to antimicrobial  
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Figure 1.1: Shape of lipid A and its influence on biological activity. The three 
dimensional structures of various types of lipid A (A), and the hypothesis linking the 
shape of lipid A to the type of receptor it binds (B) is illustrated above. Figure adapted 




peptides (Kawasaki et al., 2005). Upon recognition of the different environmental 
conditions, PhoQ activates PhoP by phosphorylation, leading to the activation of more 
than forty genes. The roles of the PhoP-PhoQ system and other activated enzymes 
were ascertained by the establishment of mutants for the specific genes (Guo et al., 
1998).  PmrA/PmrB is another two component system activated by PhoP-PhoQ that 
catalyses the substitution of Ara4N at the terminal phosphates (Zhou et al., 2001) of 
lipid A. This modification allows the bacterium to lower their affinity for cationic 
antimicrobial peptides (CAMPS) and cationic antibiotics by decreasing the overall 
negative charge of their cell surfaces (Gunn, 2001; Trent, 2004). In addition, 
PhoP-PhoQ activates lipid A palmitoyltransferase and 3-O-deacylase that catalyses 
the modification of acylation patterns of its lipid A moieties (Gibbons et al., 2005). 
These modifications have been shown to increase the virulence of the bacteria by 
enhancing intracellular survival.  
Changes to the lipid A structure of Pseudomonas aeruginosa has also been shown to 
occur in magnesium limited conditions (Ernst et al., 1999). These changes are similar 
to those identified between clinical isolates from patients with cystic fibrosis (CF) and 
environmental isolates (Ernst et al., 2007).  LPS from environmental isolates and 
laboratory adapted strains of P. aeruginosa has a penta-acylated structure. In contrast, 
the isolates from airway of CF patients synthesize hexa-acylated LPS with added 
palmitate (C16:0) and Ara4N in the lipid A moiety (Ernst et al., 1999). Consequently, 
CF LPS has been demonstrated to stimulate robust production of inflammatory 
cytokines but not the penta-acylated LPS from environmental isolates. In addition, 
only human cells are able to discriminate between the different lipid A structures of 
P. aeruginosa but not murine cells (Hajjar et al., 2002). This differential recognition 
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is due to the hypervariable 82 amino acid region in the extracellular domain of human 
TLR4 that is not present in any region of the murine TLR4.  The modifications in the 
lipid A structure of P. aeruginosa are thought to lead to the chronic colonisation of 
the airways of patients with CF, by promoting resistance to CAMPs and other active 
components of the immune system (Ernst et al., 2007).   
Yersinia pestis has similarly been shown to modulate their lipid A structure but in 
response to temperature. Y. pestis is the causative agent of plague (Aussel et al., 
2000). When Y. pestis is grown between 21oC to 27oC, the body temperature of fleas, 
the lipid A structure is mainly a hexa-acylated form. However, when the growth 
temperature is increased to 37oC, the body temperature of humans, the lipid A 
changes to a tetra-acylated form (Knirel et al., 2005). The hexa-acylated lipid A is a 
strong activator of TLR4 in humans, whereas the tetra-acylated form has very weak 
stimulatory activity (Kawahara et al., 2002). The changes in acylation patterns 
significantly contribute to the virulence of this bacterium by reducing the recognition 
by human TLR4 and hence prevent containment by local inflammation.  This allows 
Y. pestis to achieve a high bacterial load in mammalian blood required for efficient 
flea infection (Montminy et al., 2006). 
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1.5 LPS OF B. PSEUDOMALLEI  
Perry and group reported the presence of 2 types of LPS in B. pseudomallei (Perry et 
al., 1995), although later studies demonstrated that one of the LPS corresponded to 
the capsular polysaccharide that co-purified with the LPS (Isshiki et al., 2001). To 
determine the heterogeneity in LPS from different isolates, LPS from 12 strains of 
B. pseudomallei were compared using sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) from different geographical locations and the profile 
from the different strains were found to be homogenous (Pitt et al., 1992). This study 
concluded that LPS was not an important virulence factor, although the number of 
samples studied was limited. A bigger study compared LPS profiles from 214 strains 
of B. pseudomallei. With the exception of 4 isolates, the rest showed identical ladder 
patterns (Anuntagool et al., 1998). These 4 isolates were obtained from patients with a 
relapse of melioidosis. Furthermore, this atypical LPS could not react with the 
monoclonal antibody (Anuntagool et al., 2000) that was reactive against the other 
strains of LPS. In 2006, the same group compared LPS from 1,327 B. pseudomallei 
isolates (Anuntagool et al., 2006) and found a third type of LPS, which was of a 
rough form.  Although no association was found between LPS type and disease 
severity, the atypical LPS and R-LPS were found more frequently in clinical than 
environmental isolates, and more in Australian than Thai isolates. These isolates were 
also more often associated with relapse than with primary infection. The 3 LPS types 
showed similar endotoxic activity in the Limulus amoebocyte lysate (LAL) assay but 
there was a lack of immunological cross-reactivity on western blot, indicating a 
difference in host immune response (Anuntagool et al., 2000).   
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1.5.1 The role of LPS in the pathogenesis of B. pseudomallei 
LPS is the most common bacterial component that is implicated in initiating septic 
syndrome (Bosshart et al., 2007). B. pseudomallei LPS has been suggested to play a 
possible role in the pathogenesis of melioidosis because patients with septicaemic 
melioidosis (Friedland et al., 1992; Suputtamongkol et al., 1992) show significantly 
elevated levels of pro-inflammatory cytokines, the release of which is known to be 
activated by LPS in other bacterial infections. Furthermore, these patients displayed 
high levels of anti-LPS antibodies (Petkanjanapong et al., 1992). In another study, the 
level of antibody to B. pseudomallei LPS was found to be significantly higher in 
melioidosis patients who survived than in those who died.  These antibodies were also 
significantly higher in patients with nonsepticaemic than septicaemic melioidosis 
(Charuchaimontri et al., 1999). In an in-vitro model using polymorphonuclear 
leukocytes, antibodies to the LPS O-antigen of B. pseudomallei were protective 
against the pathogen by promoting phagocytic killing (Ho et al., 1997). These 
antibodies were also demonstrated to develop during human infection in a clinical 
study and this may facilitate clearance of the organisms in-vivo.    
Relatively few functional studies have focused on the LPS of B. pseudomallei.  
Recently, the O-antigen of B. pseudomallei LPS was demonstrated to modulate host 
response, as a lipopolysaccharide (LPS) mutant that lacks the O-antigenic 
polysaccharide moiety, was more susceptible to macrophage killing during the early 
phase of infection than the parental wild-type strain (Arjcharoen et al., 2007). Kinetic 
studies have shown that B. pseudomallei LPS was less stimulatory in activating RAW 
264.7 (mouse macrophage cell-line) than LPS from E. coli (Utaisincharoen et al., 
2000). Similarly, Matsuura and co-workers have demonstrated that LPS from 
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B. pseudomallei had weaker pyrogenic and lower macrophage activating activity than 
LPS from E. coli, despite inducing stronger mitogenic activity in murine splenocytes 
(Matsuura et al., 1996). Both studies seemed to indicate that the LPS of 
B. pseudomallei may be unique and is less capable in activating immune cells. Hence, 
synthesis of weakly stimulatory LPS may be one strategy used by B. pseudomallei to 
evade the immune system.    
Interestingly, B. pseudomallei LPS was able to stimulate splenocytes from C3H/HeJ 
mice that carry a loss of function mutation in TLR4 (Matsuura et al., 1996). This 
finding suggests that B. pseudomallei LPS was unique and does not stimulate pro-
inflammatory responses through TLR4. Supporting this conclusion is a recently 
published data that indicated that TLR2, and not TLR4 was involved in the signal 
transduction of B. pseudomallei LPS (Wiersinga et al., 2007).   
1.5.2 LPS as subunit vaccines 
As high levels of anti-LPS antibodies appear to be protective in melioidosis patients, 
various groups have explored using B. pseudomallei LPS as subunit vaccines. A study 
evaluating LPS and capsular polysaccharide as possible subunit vaccines against 
experimental melioidosis (Nelson et al., 2004) suggested that LPS was a potential 
vaccine candidate against melioidosis. Mice immunised with LPS developed a strong 
IgG3 and IgM response and an increased mean time to death was observed compared 
with unvaccinated controls when the mice were further challenged via the intra-
peritoneal or aerosol routes. The passive transfer of antibodies from immunized mice 
into naive animals also provided protection against a subsequent challenge with 
B. pseudomallei (Nelson et al., 2004). Another study investigated the varying 
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protection conferred to mice by various polysaccharides subunits through 
immunisation with B. pseudomallei strains with mutations in O-antigen, capsular 
polysaccharide, type III O-PS or type IV O-PS gene clusters (Sarkar-Tyson et al., 
2007). Immunization with all the polysaccharide mutant strains resulted in delayed 
time to death compared to the naive controls, when challenged with wild-type 
B. pseudomallei strain. However, contrary to previous results, immunisation with 
B. pseudomallei strains with mutations in O-antigen and capsular polysaccharide 
conferred greater protection (Sarkar-Tyson et al., 2007). This was attributed to the 
exposure of other protective surface antigens upon removal of the highly abundant 
polysaccharide. 
 22
1.6 PRELIMINARY DATA AND OBJECTIVES OF CURRENT PROJECT  
Preliminary unpublished results from our laboratory s collaborative study with 
Dr. Patrick Tan s laboratory, Genome Institute of Singapore (GIS), indicated the 
presence of an environmental transcriptional regulatory system (similar to PhoP-PhoQ 
in Salmonella serovar Typhimurium) in B. pseudomallei based on microarray data and 
sequence homology. As described above, in Salmonella serovar Typhimurium, the 
two component regulatory system (PhoP-PhoQ) has been demonstrated to detect 
changes in the environment, such as the low magnesium ion concentration in culture 
medium or macrophage phagosome (García Véscovi et al., 1996).  Based on this 
finding, it was hypothesized that environmental magnesium may also play a 
significant role in modulating the virulence in B. pseudomallei. This was supported by 
the increase in melioidosis cases during rainy seasons, where heavy rains could result 
in dilution of soil ions resulting in the increased virulence of B. pseudomallei.   
To confirm this phenomenon, the effect of magnesium on the virulence of 
B. pseudomallei was investigated using a Caenorhabditis elegans model. Wild-type 
B. pseudomallei was grown in either magnesium-supplemented or 
magnesium-minimal culture medium. Results indicated that a lower percentage of the 
worms survived when infected with B. pseudomallei cultured in magnesium minimal 
medium, signifying that B. pseudomallei became more virulent under such conditions 
(Figure 1.2). Similar phenomenon was observed with both the young adult stage worms 
and the L4 stage worms. To ascertain that the increase in virulence was not due to the 
difference in the bacterial load, the growth kinetics of B. pseudomallei in magnesium 
supplemented and magnesium minimal culture medium was investigated.  Results 
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showed that the growth of B. pseudomallei was significantly enhanced when 
extracellular magnesium was present and that growth was at least 30% slower when 
the media contained minimal amount of magnesium (Figure 1.3).    
The C. elegans model described above suggests a role of magnesium in the virulence 
of B. pseudomallei. Magnesium has been shown to play an important role in 
maintaining the outer membrane intergrity of Gram-negative bacteria and bacteria 
such as Salmonella serovar Typhimurium and P. aeruginosa are known to modulate 
host response in response to divalent cations such as magnesium with the aid of the 
PhoP-PhoQ environment regulatory system. Host response is modulated primarily 
through the modification of the lipid A moiety of LPS in these pathogens. Since our 
preliminary studies indicate the presence of a similar regulatory system in 
B. pseudomallei, and that magnesium may modulate the virulence of B. pseudomallei, 
we hypothesize that magnesium plays an important role in the virulence of 
B. pseudomallei and that virulence is determined by surface remodeling of LPS in 
response to magnesium limitation.   
Other groups have shown that the LPS of B. pseudomallei is weakly immunogenic 
and this characteristic may contribute to the ability of the bacterium to survive 
intracellularly for prolonged periods by evading host response (Utaisincharoen et al., 
2000). However, no studies have compared the functional activities of 
Burkholderia thailandensis LPS to B. pseudomallei LPS. B. thailandensis is a close 
relative of B. pseudomallei that rarely causes diseases. Hence, differences in 
functional activities between the two LPS, if any, would reveal an important possible 
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pathogenesis mechanism in B. pseudomallei. We further hypothesize that differences 
in B. pseudomallei LPS and B. thailandensis LPS may modulate host response.  
In order to evaluate the above hypotheses, the following studies were undertaken:  
1. Characterisation of LPS extracted from B. pseudomallei grown under 
magnesium rich and deficient conditions. The LPS profile was also 
compared to that of B. thailandensis.  
2. Investigation of the effect of magnesium on the LPS of B. pseudomallei in 
a cell-based in-vitro model.   
3. Detection of differences in virulence between LPS of B. pseudomallei and 
B. thailandensis.  
4. Determination of structural differences between LPS of B. pseudomallei 
and B. thailandensis.  
5. Determination of the TLR involved in the recognition of B. pseudomallei 
and B. thailandensis LPS       
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Figure 1.2: C. elegans killing assay with B. pseudomallei grown in magnesium-
supplemented and magnesium-minimal medium. +Mg and Mg indicates growth 
in magnesium-supplemented or minimal medium respectively (data courtesy of 
Sim Siew Hoon, DSO National Laboratories).  
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Figure 1.3: Growth of B. pseudomallei in magnesium-supplemented and 
magnesium-minimal medium. +Mg and Mg indicates growth in magnesium-
supplemented or minimal medium respectively. Results shown are average of 3 
experiments (data courtesy of Sim Siew Hoon, DSO National Laboratories). 

















    
Chapter 2  
Extraction of  
Lipopolysaccharides 
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2.1 INTRODUCTION  
Lipopolysaccharides (LPS) are outer membrane molecules found in Gram-negative 
bacteria (Raetz et al., 2002) and play an important role in disease caused by this group of 
bacteria (Bryn and Jantzen, 1982). Structural investigations of LPS have found that these 
molecules consist of three distinct regions (Weinbaum et al., 1971): the outermost 
regions consist of a polysaccharide chain with repeating oligosaccharide units of variable 
length, known as the O-antigen region; this is in turn connected to the core 
polysaccharide chain, which is linked to lipid A via one or more units of a unique 8 
carbon sugar, 3-deoxy-d-manno-octulosonate (KDO). Lipid A is the bio-active 
component of the LPS that is responsible for the endotoxicity of the bacteria (Rosner et 
al., 1979).  
SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis) is a simple and 
convenient method that provides information on the fundamental structure of LPS. In an 
electric field, LPS migrates towards the anode, due to the highly negatively charged lipid 
A. The LPS chains (O-antigen) with the same number of repeating sugar units will co-
migrate to give the characteristic ladder pattern common to LPS. The distance the LPS 
chain migrates depend on the length of polysaccharide chains, thus long-chain LPS move 
a short distance, whereas those with short chains or none move very close to the dye 
front.   
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The most commonly used method for the extraction of LPS from Gram-negative bacteria, 
is the hot phenol-water procedure introduced by Westphal and Jann (Westphal and Jann, 
1965). However, a review of the experimental protocol by our Institutional Biosafety 
Committee had indicated that our biosafety level-3 (BSL-3) laboratory does not have the 
necessary chemical containment to minimize the risk posed by the hazardous chemical to 
our laboratory staff. We thus took this opportunity to explore an alternative method for 
LPS extraction and characterize the resultant extract.              
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2.2 MATERIALS AND METHODS  
2.2.1 Bacterial strains and culture medium 
Burkholderia thailandensis (ATCC 700388), Salmonella enterica serovar Typhimurium 
(BAA 189), Pseudomonas aeruginosa and Klebsiella pneumoniae are risk group 2 (RG2) 
agents and were cultured in the biosafety level 2 laboratory. Burkholderia pseudomallei 
strains, BP22 and K96243 are risk group 3 (RG3) agents and were obtained from the 
B. pseudomallei collection at Defence Medical and Environmental Research Institute 
(DMERI), DSO (Kent Ridge). For growth under magnesium (Mg2+) poor and Mg2+ rich 
conditions, the basal medium used was N-minimal medium (5mM KCl, 0.5mM K2SO4, 
1mM KH2PO4, 1.8µM FeSO4.7H2O, 2µg/ml thiamine-HCl, 0.1M tris-HCl, pH7.4 and 
22mM glucose) and the Mg2+ concentration was 10mM MgSO4 for Mg2+ rich medium 
and 8µM MgSO4 for Mg2+ poor medium.  
2.2.2 Culture of RG2 bacteria for LPS extraction 
The various bacterial strains were streaked out from frozen stock and cultured for 2 days 
on TSA plates at 37oC (recovery plate).  Colonies from the recovery plate were then 
streaked onto TSA plate and cultured overnight at 37oC. The next day, one colony was 
picked and inoculated into 5ml of either Mg2+ rich (+) or Mg2+ poor ( ) N-minimal broth, 
and shaken at 200rpm for 24 hours at 37oC. The bacterial culture was passaged in the 
respective culture media for four times; each time a 1:100 dilution of overnight culture 
was inoculated into fresh broth and incubated for 24 hours at 37oC. For the fourth 
passage, 2ml of culture was inoculated into 200ml of fresh broth to prepare enough 
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bacterial culture for LPS extraction. At the end of passage four, 200ml of bacterial broth 
was centrifuged at 2000rpm for 10 minutes and the supernatant was discarded. The 
bacterial pellet was reconstituted in 10ml of respective broth. 1ml of the reconstituted 
bacterial culture was spread onto the respective + or - N-minimal agar plates and 
incubated overnight at 37oC.  
To harvest the bacteria, 6ml of the respective + or - N-minimal medium was added to 
the plates and scraped. The bacterial suspension was transferred to a pre-weighed 50ml 
falcon tube and the plates were washed with an additional 6ml of broth.  The bacteria 
suspension from 3 plates was collected in one 50ml falcon tube. The tubes were 
centrifuged at 3750rpm for 20 min at 4oC. The supernatant was aspirated and discarded. 
Each tube was re-weighed to determine the cell pellet mass. 1ml of lysis buffer (iNtRON 
LPS Extraction Kit, Intron Biotechnology) was added to every 50mg wet weight of 
bacteria. The tubes were vortexed vigorously until all cell pellets were dispersed 
completely. Tubes were stored at 4oC until use.   
2.2.3 Culture of RG3 bacteria for LPS extraction 
B. pseudomallei was cultured similarly as above with some changes.  All work was 
carried out in the BSL-3 laboratory located at DMERI, DSO (Kent Ridge). For safety 
considerations, broth cultures were shaken at 70rpm in an orbital shaker instead of 
200rpm. After harvesting the cells in lysis buffer, sterility test was conducted by 
inoculating 5% of the total volume onto TSA plates. If no bacterial growth was observed 
 31
after 48 hours of incubation, the tubes were removed from the BSL3 laboratory and 
stored at 4oC in the BSL2 laboratory until ready for further processing.   
2.2.4 LPS extraction 
As a first step, the lysis buffer and bacterial lysate mixture, which had been stored at 4oC, 
was vortexed vigorously to resuspend any lysate that could have sedimented during the 
storage. 0.2% volume of chloroform was then added to each tube, followed by a short 
vortex for 10 to 20 seconds to mix the chloroform well.  The tubes were then left at room 
temperature for a further five minutes to allow the phases to separate before centrifuging 
at 3000g for 45 minutes at 4oC using the minimum breaking force. The supernatant (top 
phase) was then harvested into clean centrifuge tubes. Two volumes of purification buffer 
(iNtRON LPS extraction kit) was added to one volume of supernatant and mixed well. 
The centrifuge tubes were placed in a -20oC freezer for 2 hours to allow the LPS to 
precipitate, following which, the tubes were centrifuged at 13000rpm for 15 minutes at 
4oC in a high-speed centrifuge. The supernatant was discarded and the pellet was washed 
twice with 70% ethanol. Finally, the pellet was air-dried, lyophilized and stored at 4oC 
until LPS analysis.  
2.2.5  Whole cell LPS profile 
One full loop of bacterial lawn was harvested from the agar plates (passage 5) and 
transferred into a pre-weighed 1.5ml micro-centrifuge tube. The micro-centrifuge tube 
was reweighed and 50 l of solubilisation buffer was added to every milligram of 
bacteria.  The bacterial cells were then resuspended by vortexing to break up cell clumps. 
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This suspension was heated at 99oC for 10 minutes to kill and homogenize bacteria with 
occasional vortexing during the heating. After heating, an equal volume of solubilisation 
buffer containing proteinase K (100 g for every 30 l of solubilisation buffer) was added 
and the bacteria were heated at 60oC for 2 hours. Finally the proteinase K was inactivated 
by boiling for 10 minutes. The sample was stored at -20oC until use.   
For work with bacterial strains requiring BSL-3 containment, after heating at 99oC for 
10 minutes to kill and homogenize bacteria, a sterility test was conducted. 25 l of the 
homogenate was inoculated onto TSA plate and incubated for 48 hours at 37oC in an 
incubator. If no growth was observed, the samples were considered sterile and brought 
out of the BSL3 laboratory. The protocol was continued in the biosafety level 2 (BSL2) 
laboratory with the addition of solubilisation buffer containing proteinase K.   
2.2.6  SDS-PAGE analysis 
SDS-PAGE was carried out using 16% resolving gel. LPS or whole cell lysate was 
loaded per well. After electrophoresis, the separated components were detected using the 
Pro-Q® Emerald 300 Lipopolysaccharide Gel Stain Kit (Invitrogen, Singapore). Stained 
gels were visualized using a 300 nm UV trans-illuminator. 
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2.3 RESULTS  
The LPS from Salmonella serovar Typhimurium, P. aeruginosa, K. pneumoniae, 
B. thailandensis and B. pseudomallei were extracted using an alternative extraction 
method (iNtRON LPS Extraction Kit). To compare if the LPS obtained using this kit was 
representative of the whole LPS from the bacterium, crude LPS was obtained from whole 
cells using proteinase K digestion.   
Figure 2.1 shows the profile of LPS from Salmonella serovar Typhimurium obtained 
from the kit. The ladder pattern obtained was similar to the whole cell LPS profile. No 
missing bands were observed. Although the ladder pattern was similar, a slight difference 
was observed between the LPS obtained from Salmonella serovar Typhimurium grown 
under Mg2+ rich and Mg2+ poor N-minimal medium. Similarly no difference was seen in 
the LPS profile of P. aeruginosa (Figure 2.2)  
Figure 2.3 shows the LPS profile of B. thailandensis. The LPS profile of B. thailandensis 
did not have the characteristic ladder pattern seen in the LPS profile of Salmonella 
serovar Typhimurium. The LPS profile was similar to the whole cell LPS profile with the 
exception of an additional band of intermediate molecular weight that was present when 
the kit extraction method was used. Similar profile was observed between bacteria grown 
under Mg2+ rich and Mg2+ poor conditions.  
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Similar to B. thailandensis, B. pseudomallei (Figure 2.4) did not show any difference in 
the ladder pattern between the Mg2+ rich and Mg2+ poor conditions. An additional band of 
intermediate molecular weight was also observed when the extraction kit was used. 
Furthermore, LPS profile from B. pseudomallei was similar to that of B. thailandensis.   
K. pneumoniae is an excessively capsulated bacterium. To check if the kit extraction 
method was suitable for the extraction of LPS from such bacteria, we compared the LPS 
profile to that of the whole cell LPS (Figure 2.5). Unlike the other bacteria studied here, 
we were unable to obtain a proper LPS profile even from the whole cell lysate. A smear 
pattern, characteristic of capsular polysaccharide was observed.               
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Figure 2.1: SDS-PAGE profile of Salmonella serovar Typhimurium LPS. LPS was 
extracted using an LPS extraction kit (A) and compared to the whole cell LPS profile (B). 
Lanes 1 and 3 represent LPS extracted from bacteria grown under Mg2+ rich medium and 
lanes 2 and 4 represent LPS extracted from bacteria grown under Mg2+ poor medium.  
                                  
A B 
 1   2  3   4
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Figure 2.2: SDS-PAGE profile of P. aeruginosa LPS. LPS was extracted using an LPS 
extraction kit (A) and compared to the whole cell LPS profile (B). Lanes 1 and 3 
represent LPS extracted from bacteria grown under Mg2+ rich medium and lanes 2 and 4 
represent LPS extracted from bacteria grown under Mg2+ poor medium.         
B 
 1       2
 3          4
A 
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Figure 2.3: SDS-PAGE profile of B. thailandensis LPS. LPS was extracted using an 
LPS extraction kit (A) and compared to the whole cell LPS profile (B). Lanes 1 and 3 
represent LPS extracted from bacteria grown under Mg2+ rich medium and lanes 2 and 4 
represent LPS extracted from bacteria grown under Mg2+ poor medium. Arrow indicates 
band present in kit extracted LPS but absent in whole cell LPS.          
A B 
 1       2  3       4
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Figure 2.4: SDS-PAGE profile of B. pseudomallei LPS. LPS was extracted using an 
LPS extraction kit (A) and compared to the whole cell LPS profile (B). Lanes 1 and 3 
represent LPS extracted from bacteria grown under Mg2+ rich medium and lanes 2 and 4 
represent LPS extracted from bacteria grown under Mg2+ poor medium. Arrow indicates 
band present in kit extracted LPS but absent in whole cell LPS.         
               
A B 
 1       2 3       4
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Figure 2.5: SDS-PAGE profile of K. pneumoniae LPS. LPS was extracted using an 
LPS extraction kit (A) and compared to the whole cell LPS profile (B). Lanes 1 and 3 
represent LPS extracted from bacteria grown under Mg2+ rich medium and lanes 2 and 4 
represent LPS extracted from bacteria grown Mg2+ poor medium.            
A B 
 1       2  3       4 
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2.4 DISCUSSION  
Several methods exist for the extraction of LPS from Gram-negative bacteria. The most 
efficient and commonly used method is the hot phenol-water procedure introduced by 
Westphal and Jann (Westphal and Jann, 1965). This procedure is based on the theory that 
proteins are soluble in the phenol phase and LPS in the water phase, enabling the 
extraction of LPS from the aqueous phase. The hot phenol-water method has gone 
through several modifications and specific methods have been introduced for rough and 
smooth types of LPS. For rough type bacteria, an extraction method (PCP) involving a 
solvent mixture of aqueous phenol, chloroform and petroleum ether was developed 
(Galanos et al., 1969). However, all of the above methods require the use of phenol, 
which is toxic and consequently dialysis is needed to remove the phenol. This also makes 
the procedure complex and time-consuming. Also, in some instances, LPS may be 
recovered from the phenol phase instead. Darveau and Hancock (1983) proposed a 
method that was suitable for the isolation of both smooth and rough LPS without the 
requirement of phenol, although the need for a multi-step procedure has probably resulted 
in many investigators shunning this method of extraction (Darveau and Hancock, 1983). 
Other new methods have been proposed for the extraction of LPS. These include the 
extraction of LPS from small quantities of cells (Li et al., 1998) or the use of an RNA-
isolating agent (Yi et al., 2000). However, these methods still require 2 to 3 days for the 
extraction or the use of phenol. El Hamidi and colleagues (2005) introduced a new lipid 
A micro-isolation method that allows the direct isolation of lipid A from whole bacterial 
cells (El Hamidi et al., 2005). Although this method takes just a day and is broadly 
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applicable to different Gram-negative bacteria, it allows only the extraction of rough-type 
LPS.   
The LPS from B. pseudomallei is usually obtained using the hot phenol-water based 
procedure. However, it was shown upon separating the phases, only 0.7% of LPS enters 
the aqueous phase while 3.5% enters the phenol phase (Perry et al., 1995). Chemical 
analyses also showed that the aqueous product was essentially a rough type of LPS and 
the smooth type of LPS was essentially in the phenol phase. Hence, all groups working 
on this LPS have since combined the 2 phases to obtain the maximal amount of LPS. 
However the high molecular weight capsular polysaccharide expressed by the virulent 
isolates of B. pseudomallei also partitions together with the LPS into the phenol phase 
(Brett et al., 2007). Removal of the capsular polysaccharide is difficult and would require 
the use of size exclusion chromatography.  
Due to the above reasons, and that we were unable to use the hot phenol-water method in 
our BSL3 facilities for safety reasons, we searched for an alternative method for the 
extraction of LPS. The LPS extraction kit from Intron Biotechnology has been used by 
several groups for the extraction of LPS from bacteria such as Salmonella species 
(Baldauf et al., 2007), and P. aeruginosa (Bucki et al., 2007). The kit extraction method 
is based on the hot phenol-water method, but without the need of hot phenol. In the kit 
extraction method, the bacterial cell membranes are disrupted with the provided aqueous 
lysis buffer, which consists of a mixture of chemicals, including a low concentration of 
phenol. Compared to the hot phenol-water method, the need for mechanical cell 
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disruption and heating are eliminated, and hence is safe for use in the BSL3 facilities. To 
isolate the aqueous phase LPS, chloroform is used to separate the phenol and aqueous 
phase. After centrifugation, the aqueous layer is isolated and the LPS is precipitated with 
the provided purification buffer, waiving the need for extensive dialysis as required in the 
hot phenol-water method. By avoiding the phenol phase, the possible contamination with 
capsular polysaccharide is also reduced significantly (Brett et al., 2007). Since for some 
bacteria, LPS may be associated strongly with outer-membrane proteins causing them to 
enter the phenol phase, the LPS extracted using the kit was compared to whole cell LPS 
profile to enable the detection of such LPS.    
This study is focused on LPS from B. pseudomallei and B. thailandensis. However, to 
determine the suitability of the extraction method, we also extracted LPS from 
Salmonella serovar Typhimurium, P. aeruginosa and K. pneumoniae. With the exception 
of K. pneumonia, the LPS extraction kit was suitable for the extraction of LPS from the 
other bacteria tested here. Although LPS from B. pseudomallei and B. thailandensis 
showed an extra band of intermolecular weight compared to whole cell lysate, these 
bands probably coincide with those from smooth LPS, which have been shown in 
B. pseudomallei to migrate into the phenol phase (Perry et al., 1995). The bands are not 
likely to be due to protein contaminants as the staining used for the visualization of the 
gel is specific for LPS. Conventionally, LPS patterns are detected using silver staining. 
However, silver staining cannot differentiate LPS from proteins in the sample. The 
staining method used here stains only the periodate-oxidized carbohydrate groups, and 
hence is specific for the staining of LPS.  
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A difference was noted in the LPS ladder appearance of Salmonella serovar 
Typhimurium grown under Mg2+ rich and Mg2+ poor conditions. Although it is known 
that the lipid A of Salmonella serovar Typhimurium is modulated under varying 
magnesium concentrations (García Véscovi et al., 1996), changes in the ladder pattern 
was not expected. This phenomenon seen here may be due to the different loading of 
LPS. Changes in LPS profile between Mg2+ rich and poor conditions were not seen for 
P. aeruginosa, B. pseudomallei and B. thailandensis. This is expected as SDS-PAGE 
LPS profile is not sensitive enough to detect changes in lipid A, which is the lowest 
molecular weight band in the gel. Changes in fatty acid acylation of lipid A will require 
further structural analysis. 
   
Chapter 3  
Determination of the effect of 
magnesium on the virulence of  
Burkholderia pseudomallei. 
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3.1 INTRODUCTION  
Some Gram-negative bacteria have evolved mechanisms to modify their structures in 
different environments. This alteration in the pattern recognition motif delays or evades 
recognition by the innate immune system, hence subverting host immune response. For 
example, Salmonella enterica serovar Typhimurium is able to modify its lipid A 
molecules via the activation of a two component regulatory system PhoP-PhoQ (García 
Véscovi et al., 1996). PhoQ is a kinase that senses the different environmental conditions, 
such as the reduced pH inside the macrophage phagosome, or the exposure to 
antimicrobial peptides, which destabilises the bacterial membrane (Fields et al., 1989; 
Kawasaki et al., 2005). This results in the activation of genes that enable the bacterium to 
respond to such environmental stimuli appropriately, enhancing its chances of survival.  
In both prokaryotes and eukaryotes, magnesium (Mg2+) is a membrane and ribosome 
stabilizer and is essential in reactions requiring ATP (Reinhart, 1988). In some bacteria, 
Mg2+ is the signal that regulates the PhoP/PhoQ system, which in turn controls several 
pathogenic properties of the facultative intracellular parasite including intra-macrophage 
survival (Fields et al., 1986). In the case of Salmonella serovar Typhimurium, low Mg2+ 
environment mimics the macrophage phagosomal environment; sensing of the host 
environment (phagosome) enables the bacterium to resist host cationic antimicrobial 
peptides (CAMPS) and cationic antibiotics by decreasing the overall negative charge of 
their cell surfaces (Zhou et al., 2001). This provides a competitive edge to the survival of 
the pathogen.  
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To date, much of the intricacies of Burkholderia pseudomallei pathogenesis remain to be 
elucidated and dissecting the molecular basis underlying bacterial virulence may provide 
new insights into the disease process. Preliminary unpublished results from our 
collaboration with Dr Patrick Tan s laboratory at the Genome Institute of Singapore 
indicated the presence of an environmental transcriptional regulatory system similar to that 
of Salmonella serovar Typhimurium, based on microarray and sequence homology data. 
Upon further investigation, we found that B. pseudomallei exhibited increased virulence 
when cultured in N-minimal medium containing low concentration of Mg2+ in a 
Caenorhabditis elegans model. Hence, the focus of the study in this chapter is to 
investigate the effects of low magnesium concentration on the LPS of B. pseudomallei. 
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3.2 MATERIALS AND METHODS  
3.2.1 Cell culture 
RAW 264.7 (mouse macrophage cell-line) and THP-1 (human monocyte cell-line) were 
purchased from American Type Culture Collection (ATCC).  RAW 264.7 was cultured at 
37°C in a humidified incubator (95 % air with 5% CO2) in Dulbecco's Modified Eagle's 
Medium (DMEM) containing 10% fetal bovine serum (FBS) and sub-cultured every 3 to 
4 days at a split ratio of 1:6. THP-1 cells were grown in suspension in RPMI 1640 with 
10% FBS and 2mM L-glutamine and sub-cultured once a week at a ratio of 1:10.   
3.2.2  Optimisation of the priming of THP-1 cells 
THP-1 cells were primed for 8, 14 or 24 hours with 10 or 100ng/ml of phorbol 12-
myristate 13-acetate (PMA). After priming, cells were washed with sterile phosphate 
buffered saline (PBS) twice, and complete medium added. Cells were allowed to rest for 
24 hours to ensure that they revert to a resting phenotype before stimulation with 
100ng/ml of commercial Salmonella serovar Typhimurium LPS (Sigma, Singapore) for 
24 hours. The priming and stimulation of cells were monitored by light microscopy, and 
production of TNF- to choose the optimal parameters for priming. The optimal 
concentration of PMA and length of priming was chosen for subsequent studies.  
3.2.3 LPS stimulation assay 
For RAW 264.7, 5 x 105 cells were seeded per well in a 6-well plate and incubated 
overnight prior to LPS stimulation assay. For THP-1 cells, 1 x 106 cells, stimulated with 
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10ng/ml PMA were seeded into each well of a 6-well plate. After 24 hours incubation, 
culture medium was removed and the cells were washed twice with PBS before fresh 
medium was added. THP-1 cells were allowed to rest for further 24 hours before being 
used for the LPS stimulation assay.  
Both RAW 264.7 and THP-1 cells were stimulated with increasing concentration of LPS 
extracted from B. pseudomallei and B. thailandensis grown under Mg2+ rich or Mg2+ poor 
N-minimal medium. LPS extracted from Salmonella serovar Typhimurium was used as a 
control. Assay was carried out for 12 and 24 hours, respectively and the cell culture 
supernatant was quantitated for various cytokines (TNF- , IL-10 and MCP-1) using 
Quantikine ELISA kits (R&D Systems, Minneapolis, MN).   
3.2.4 Fatty Acid extraction and analysis 
4ml of methanolic HCl was added to 8mg of extracted LPS, and was heated for 18 hours 
at 90oC in a Teflon-lined screw capped glass tube. Pentadecanoic acid was used as an 
internal standard. After overnight incubation, an equal volume of 50% saturated NaCl 
solution was added, and the fatty acid methyl esters were extracted with chloroform. 
Nitrogen gas was used to concentrate the extracted methyl esters to almost dryness but 
not completely and analysed by gas chromatography mass-spectrometry (GC-MS).  
3.2.5 Statistical analysis  
Cytokine production was analysed by unpaired Student s t test (2-tailed distribution). 
Values of p<0.05 were considered statistically significant.  
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3.3 RESULTS  
3.3.1 Analysis of fatty acids in lipid A 
Six different LPS extracts were analysed by GC-MS and the results are shown in 
Table 3.1. Modifications in the lipid A structure, when exposed to Mg2+ limiting 
environment are well characterized in Salmonella serovar Typhimurium (Guo et al., 
1997). Hence, LPS was extracted from this bacterium cultured in either Mg2+ rich or 
Mg2+ poor N-minimal medium and used as a positive control to detect changes in lipid A. 
When cultured in Mg2+ rich N-minimal medium, dodecanoic acid (C12:0), tetradecanoic 
acid (C14:0) and 3-hydroxy-tetradecanoic acid [C14:0(3-OH)] were the fatty acids 
detected in the lipid A of Salmonella serovar Typhimurium. When Mg2+ poor N-minimal 
medium was used to culture the bacteria, 2-hydroxy-tetradecanoic acid [C14:0(2-OH)] 
and hexadecanoic acid (C16:0) were present in addition to the above fatty acids.   
Our analysis also showed that B. pseudomallei and B. thailandensis (Table 3.1) had 
different fatty acid composition compared to Salmonella serovar Typhimurium. C12:0 
was absent in the LPS of both B. pseudomallei and B. thailandensis but present in 
Salmonella serovar Typhimurium. Another major difference was the presence of 
3-hydroxy hexadecanoic acid [C16:0 (3-OH)] in the lipid A of B. pseudomallei and 
B. thailandensis but was not found in Salmonella serovar Typhimurium.   
The lipid A fatty acid composition in B. pseudomallei was also different from that of 
B. thailandensis  (Table 3.1). The LPS extract from B. thailandensis lacked C14:0(2-
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Table 3.1: Fatty acid composition of LPS from B. pseudomallei1, B. thailandensis1 
and Salmonella serovar Typhimurium1.  
B. pseudomallei B. thailandensis 
Salmonella serovar 
Typhimurium LPS  
+Mg  -Mg  +Mg -Mg +Mg  -Mg 
C12:0 x2 x x x 
C14:0 
C14:0(2-OH) x x x 
C14:0(3-OH) 
C16:0 x 
C16:0(3-OH) x x 
1 Bacteria were cultured in either Mg2+ rich (+Mg) or Mg2+ poor (-Mg) N-minimal 
medium.   
2 
 and x indicates the presence and absence of the corresponding fatty acid, respectively.  
 50 
OH) compared to B. pseudomallei, although the profile of the other fatty acids in the 
LPS molecule was qualitatively similar. No difference in the fatty acid composition of 
their lipid A was observed, when either of these two species of bacteria was cultured in 
Mg2+ rich or Mg2+ poor N-minimal medium.  
3.3.2 Effect of magnesium on the virulence of B. pseudomallei LPS in human 
monocytes  in-vitro 
To determine the optimal conditions required to prime THP-1 cells, phorbol 12-myristate 
13-acetate (PMA) was included in the culture medium for 8, 14 or 24 hours at a 
concentration of 10 or 100ng/ml. The priming and stimulation of cells were monitored by 
light microscopy, and TNF- protein measurement. Priming with 10ng/ml of PMA for 24 
hours was found to be optimal. Higher concentrations of PMA were toxic to the cells and 
priming for less than 24 hours was not sufficient to stably activate cells. Figure 3.1 shows 
the morphology of the cells after priming with 10ng of PMA. THP-1 cells are suspension 
cells (Figure 3.1A), which upon priming with PMA for 24 hours (Figure 3.1B), form 
spindle-like adherent cell monolayer in the flask. The cells remained adherent during the 
next 24 hours of recovery (Figure 3.1C) and upon stimulation with 100ng/ml of 
commercial Salmonella serovar Typhimurium LPS (Figure 3.1D) assumed a 
macrophage-like morphology.   
To ensure that basal levels of TNF- was not affected by PMA priming and that the cells 
would be able to respond to LPS stimulation, increasing concentrations of commercial 
Salmonella serovar Typhimurium LPS was added to 1 x 106 of THP-1 cells (Figure 3.2).  
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Figure 3.1: Morphology of THP-1 cells primed with PMA. (A) Normal THP-1 
(x 20), (B) THP-1 stimulated with 10ng/ml PMA for 24 hours (x 20), (C) Primed 
THP-1 after 24 hours of recovery (x 20), and (D) primed THP-1 stimulated with 
100ng/ml of commercial Salmonella serovar Typhimurium LPS for 24 hours after 




At basal levels, without LPS stimulation, no differences in TNF- concentration between 
primed and unprimed cells was observed. Upon PMA stimulation, the cells were able to 
respond to LPS in a dose-dependent manner. Hence, the parameters for THP-1 priming 
were fixed as mentioned above.   
Primed THP-1 cells were stimulated with increasing concentrations of LPS from 
Salmonella serovar Typhimurium, B. thailandensis and B. pseudomallei cultured in Mg2+ 
rich or Mg2+ poor N-minimal medium (Figure 3.3). THP-1 cells were able to respond to 
LPS from all three species in a dose dependent manner. LPS extracted from Salmonella 
serovar Typhimurium cultured in Mg2+ poor medium, was significantly more potent in 
activating THP-1 cells than LPS from bacteria cultured in Mg2+ supplemented medium 
(p<0.05), when 0.1ng/ml to 100ng/ml of LPS was used. Regardless of the culture 
medium used to grow the bacteria, LPS from both B. pseudomallei and B. thailandensis 
showed no significant difference (p>0.05) in stimulating TNF- production from THP-1 
cells.   
3.3.3 Effect of magnesium on the virulence of B. pseudomallei LPS in mouse 
macrophages  in-vitro 
To check if mouse macrophages would respond to LPS differently from human cells, 
RAW 264.7 mouse macrophage cell-line was stimulated with LPS extracted from 
Salmonella serovar Typhimurium, B. thailandensis and B. pseudomallei cultured in either 
Mg2+ rich or Mg2+ poor medium. Figures 3.4, 3.5 and 3.6 show the cytokine profile of 
increasing concentrations of LPS on TNF- , MCP-1 and IL-10 production, 
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Figure 3.2: Effect of priming on TNF- production. THP-1 cells were primed with 
10ng/ml of PMA for 24 hours. After resting for 24 hours, primed and unprimed cells 
were stimulated with commercial Salmonella serovar Typhimurium LPS for 24 hours. 
Data-points represent the mean of 3 independent experiments and error bars represent the 
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Figure 3.3: TNF- production in primed THP-1 cells. Primed THP-1 cells were 
stimulated with LPS from Salmonella serovar Typhimurium (A), B. pseudomallei (B) and 
B. thailandensis (C), and were assayed for levels of TNF- . Data-points represent the 
mean of 3 independent experiments and error bars represent standard deviation. + and 
- represent LPS extracted from bacteria cultured in Mg2+ rich or Mg2+ poor N-minimal 





respectively. RAW 264.7 produced significantly more TNF- and MCP-1 when 
stimulated with 10 to 1000ng/ml of LPS extracted from Salmonella serovar Typhimurium 
cultured in Mg2+ poor medium than Mg2+ rich medium. There was no difference in TNF- 
and MCP-1 production when RAW 264.7 was stimulated with LPS extracted from 
B. pseudomallei and B. thailandensis grown in either Mg2+ rich or Mg2+ poor N-minimal 
medium. Generally, the level of IL-10 produced by RAW 264.7 was low when stimulated 
with LPS from the three species. A significant level of IL-10 production could be 
detected only when the cells were stimulated with 1000ng/ml of LPS. RAW 264.7 
produced more IL-10 in response to 1000ng/ml of LPS extracted from only Salmonella 
serovar Typhimurium cultured in Mg2+ poor than Mg2+ rich N-minimal medium. No 
difference in IL-10 expression was detected when stimulated with LPS from 
B. pseudomallei and B. thailandensis cultured in either Mg2+ rich or Mg2+ poor 



























































Figure 3.4: TNF-  production in RAW 264.7. RAW 264.7 were stimulated with LPS 
from Salmonella serovar Typhimurium (A), B. pseudomallei (B) and B. thailandensis 
(C), and were assayed for levels of TNF- . Data-points represent the mean of 3 
independent experiments and error bars represent standard deviation. + and - represent 
LPS extracted from bacteria cultured in Mg2+ rich or Mg2+ poor N-minimal medium, 












































































Figure 3.5: MCP-1 production in RAW 264.7. RAW 264.7 were stimulated with LPS 
from Salmonella serovar Typhimurium (A), B. pseudomallei (B) and B. thailandensis 
(C), and were assayed for levels of MCP-1. Data-points represent the mean of 3 
independent experiments and error bars represent standard deviation. + and - represent 
LPS extracted from bacteria cultured in Mg2+ rich or Mg2+ poor N-minimal medium, 

































































Figure 3.6: IL-10 production in RAW 264.7. RAW 264.7 were stimulated with LPS 
from Salmonella serovar Typhimurium (A), B. pseudomallei (B) and B. thailandensis 
(C), and were assayed for levels of IL-10. Data-points represent the mean of 3 
independent experiments and error bars represent standard deviation. + and - represent 
LPS extracted from bacteria cultured in Mg2+ rich or Mg2+ poor N-minimal medium, 





3.4 DISCUSSION  
Preliminary results based on a C. elegans infection model suggested that Mg2+ deficiency 
in the bacterial environment alters the virulence phenotype of B. pseudomallei. Increased 
death was observed in nematodes infected with B. pseudomallei cultured in magnesium 
minimal medium, suggesting that B. pseudomallei became more virulent under such 
conditions. As intact LPS is required for Salmonella mediated induction of programmed 
cell death in C. elegans (Aballay et al., 2003) and others have demonstrated that bacteria 
such as Salmonella serovar Typhimurium and Pseudomonas aeruginosa alter their lipid A 
in response to low Mg2+ concentrations resulting in increased virulence (Guo et al., 1997; 
Hajjar et al., 2002), the findings prompted our investigation into the LPS of 
B. pseudomallei..  
Since lipid A changes in Salmonella serovar Typhimurium are well characterized, LPS 
was extracted from this bacteria cultured in Mg2+ rich or poor N-minimal medium and used 
as a positive control to confirm changes in lipid A fatty acid composition. When cultured in  
Mg2+ poor medium, C14:0 (2-OH) and C16:0 were found in addition to the fatty acids 
present in LPS of bacteria cultured in Mg2+  rich medium.  The differences observed in the 
fatty acid composition were similarly identified by other groups (Guo et al., 1998; Zhou et 
al., 2001). In this study, no changes were detected in the lipid A fatty acid composition of 
either B. pseudomallei or B. thailandensis cultured in different Mg2+   concentrations.   
Exposure to low magnesium environment not only alters the fatty acid composition of lipid 
A, but may alter other structural components of lipid A. For example, the phosphate groups 
 60
of lipid A from Salmonella serovar Typhimurium and P. aeruginosa become modified 
with 4-amino-4-deoxy-arabinose (Ara4N) upon exposure to low concentrations of Mg2+ 
(Ernst et al., 2006; Guo et al., 1997). Modification with Ara4N increases the virulence of 
bacteria by conferring resistance to host cationic antimicrobial peptides. Based on this 
knowledge, we further investigated the effect of magnesium on the virulence of 
B. pseudomallei LPS in-vitro. However, the LPS from B. pseudomallei cultured in either 
Mg2+ rich or Mg2+ poor medium were similarly recognized by murine macrophages 
(RAW 264.7).    
Lipid A modifications in P. aeruginosa are differentially recognized by murine and 
human cells in-vitro (Hajjar et al., 2002). Since mouse macrophage cells could not 
distinguish B. pseudomallei LPS extracted from bacteria cultured in either Mg2+ rich or 
Mg2+ poor medium, we further investigated the ability of human monocytes (THP-1) to 
differentiate the two LPS. Similar to RAW 264.7, THP-1 was unable to distinguish 
B. pseudomallei LPS extracted from Mg2+ rich from Mg2+ poor medium.   
The results in this study indicates that Mg2+ does not modulate the virulence phenotype of 
B. pseudomallei and B. thailandensis LPS. The contrary findings in our preliminary 
study, where under magnesium deficient conditions B. pseudomallei exhibited increased 
virulence in C. elegans, could be a consequence of the primitive immune system of 
C. elegans (Wiles et al., 2006). Environmental magnesium may also modify the virulence 
phenotype of B. pseudomallei by inducing modifications other than LPS.   
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In conclusion, contrary to our hypothesis, Mg2+ deficiency does not alter the fatty acid 
composition of lipid A from B. pseudomallei and B. thailandensis. In addition, both 
murine and human macrophages are unable to differentiate the LPS extracted from 
bacteria cultured in Mg2+ rich or Mg2+ poor N-minimal medium in both B. pseudomallei 
and B. thailandensis in-vitro. Interestingly, differences were observed in the LPS fatty 
acid composition between B. pseudomallei and B. thailandensis. These changes may 
contribute to the different virulence observed in humans and requires further 
investigation. 
   
Chapter 4  
Structural and biological 
characterization of lipid A from  
B. pseudomallei and  
B. thailandensis 
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4.1 INTRODUCTION  
A key pathway for the induction of inflammation in response to Gram-negative bacteria 
is the activation of innate immune system by lipopolysaccharide (LPS). LPS is 
recognized by the immune system as a marker of bacterial invasion. It is responsible for 
the development of inflammatory response to combat the infection (Medzhitov, 2001).  
However, the induction of uncontrolled and excessive levels of innate inflammatory 
response leads to septic shock. The endotoxic activity of lipid A varies strongly with its 
primary structure, namely the fatty acids, polar heads and carbohydrate components 
(Seydel et al., 2000).   
The architecture of lipid A is usually the most conserved within a genus, compared to the 
core polysaccharide and O-antigen (Leone et al., 2007). The fatty acid composition of 
LPS from Burkholderia mallei, Burkholderia cepacia and Burkholderia caryophylli 
consist of tetradecanoic acid (C14:0), 3-hydroxy-tetradecanoic acid [C14:0(3-OH)] and 
3-hydroxy-hexadecanoic acid [C16:0 (3-OH)] (Brett et al., 2007; Molinaro et al., 2003; 
Silipo et al., 2005). These fatty acids were also detected in the LPS of B. pseudomallei 
and B. thailandensis as described in Chapter 3 of this thesis. Of note is that, although no 
differences were found in the fatty acid composition of B. pseudomallei or 
B. thailandensis when cultured under varying magnesium concentration, the presence of 
2-hydroxy-tetradecanoic acid [C14:0(2-OH)] was detected only in the LPS of 
B. pseudomallei (Table 3.1, Chapter 3) and not in B. thailandensis. The fatty acid 
analysis carried out in chapter 3 was able to determine only the fatty acid components of 
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lipid A, and could not be used to determine the detailed structure of the lipid A moiety of 
LPS. As the shape of the lipid A component of LPS may influence its biological activity 
(Netea et al., 2002; Seydel et al., 2000), this chapter sought to characterize the unique 
structural features of the lipid A moiety of B. pseudomallei, and compare to that of 
B. thailandensis.    
Preliminary mass spectrometry data indicated the presence of impurities that made 
structural interpretation challenging. Hence, the use of a recently published method on 
LPS purification was explored and its suitability in purifying the extracted LPS was 
assessed. In addition, a side by side comparison of the biological activities of 
B. pseudomallei LPS and B. thailandensis LPS were investigated to determine if the 
differences detected in the lipid A structure in B. pseudomallei and B. thailandensis were 
recognized by immune cells in-vitro.           
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4.2 MATERIALS AND METHODS  
4.2.1 Removal of proteins, DNA and RNA from LPS 
LPS was dissolved in phosphate buffered saline (PBS) containing 0.001M CaCl2 and 
0.001M MgCl2 at a concentration of 10mg/ml. RNase A and DNase I was added to a final 
concentration of 10µg/ml and the mixture was incubated at 37oC for 4 hours. After 
incubation, proteinase K was added to a final concentration of 10µg/ml and the sample 
was incubated for 2 hours at 37oC. The sample was then ultra-centrifuged at 100,000g for 
6 hours. The supernatant was removed, and the pellet was washed twice with double 
distilled water. Finally, the sample was dissolved in water and lyophilized in a 
pre-weighed micro-centrifuge tube. The removal of proteins and nucleic acids were 
monitored by taking the absorbance of the LPS at 280nm and 260nm, respectively with a 
spectrophotometer.  
4.2.2  Removal of TLR2 activating contaminants from LPS 
After removal of proteins and nucleic acids, LPS was further purified to remove TLR2 
activating contaminants (Tirsoaga et al., 2007). 10mg of LPS was suspended in 1M 
hydrochloric acid (HCl) at a concentration of 20mg/ml, and sonicated in an ultrasonic 
bath for 2 minutes. Chloroform and methanol were added to the mixture to achieve a final 
ratio of 3:2:0.25 (chloroform: methanol: 1M HCl, v:v:v). The suspension was sonicated 
for 2 minutes and then centrifuged at 2000g for 10 minutes. The supernatant was 
separated from the pellet and the pellet was dried under a stream of nitrogen. The above 
extraction was repeated twice and followed by two extractions using water instead of 
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HCl. Finally, the dried pellet was re-suspended in water and centrifuged at 300,000g for 
45 minutes at 4oC. The supernatant was discarded, and the pellet corresponding to 
purified LPS was dissolved in water and lyophilized overnight.   
4.2.3 LPS stimulation assay 
RAW 264.7 were seeded in 24 well plates at a density of 2.5 x 104 cells/well and 
incubated overnight prior to LPS stimulation assay. The next day, RAW 264.7 cells were 
stimulated with increasing concentrations of crude or purified LPS from B. pseudomallei 
and B. thailandensis for 16 hours. Purified LPS from Escherichia coli strain K12 
(InvivoGen, San Diego, CA) was used as a control. The supernatant was analyzed for 
TNF- , IL-6 and IL-10 release using Quantikine ELISA (R&D Systems, Minneapolis, 
MN). Cytokine production was analyzed by unpaired Student s t test (2-tailed 
distribution). Values of p<0.05 were considered statistically significant.  
4.2.4 Isolation of lipid A 
Lipid A was isolated from LPS using modified mild acid hydrolysis (Yi et al., 2000). 
1mg of LPS was dissolved in 500µl of 1% SDS in 10mM sodium acetate, pH 4.5 and 
placed in a ultrasound bath to dissolve the sample. The sample was heated at 100 °C for 1 
hour, after which the mixture was dried under vacuum in a speed-vac. To remove SDS, 
the dried pellet was suspended in 100µl of distilled water and sonicated in an ultrasonic 
bath to disperse the sample. 500µl of acidified ethanol (prepared by adding 100µl of 
4M HCl to 20ml of 95% ethanol) was added to the suspension and centrifuged at 2000g 
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for 10 minutes. The pellet was washed twice more with 500µl of non-acidified ethanol 
and lyophilized to obtain lipid A.  
4.2.5 ESI/QTOF mass spectrometry  
Electrospray Ionization Mass Spectrometry (ESI/MS) was performed on a Waters 
Micromass Q-TOF micro mass spectrometer (Waters Corp., Milford, MA). The capillary 
voltage and sample cone voltage were maintained at 3.0kV and 55V, respectively. The 
source temperature was 80°C, and the desolvation temperature was set at 250°C. Mass 
spectra were acquired in the negative ion mode.  Isolated lipid A was re-suspended in 
chloroform:methanol 2:1 (v/v) containing 3% of 300mM piperidine as an ion signal 
enhancer.  Sample was directly infused into mass spectrometer at a flow rate of 10µl/min. 
Negative ESI/MS/MS analyses were carried out under similar conditions except for 
collision energies. The major peaks identified in the ESI/QTOF mass spectra were 
investigated using tandem MS either through ESI/MS/MS or HPLC/ESI/MS/MS with 
collision energies varying from 35 to 80 volts, and argon was used as the collision gas.  
4.2.6 Contribution of authors towards experimental data in this chapter 
Removal of proteins, DNA, RNA and TLR2 contaminating proteins from LPS, LPS 
stimulation assay, fatty acid analysis and significance of structural differences were 
carried out by Vidhya Novem. Isolation of lipid A was jointly carried out by Vidhya 
Novem and Dr Shui Guanghou in Associate Professor Markus Wenk s laboratory 
(Department of Biochemistry, NUS). ESI/QTOF mass spectrometry and ESI/MS/MS 
analyses of lipid A were carried out by Dr Shui Guanghou. 
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4.3 RESULTS  
4.3.1 Repurification of LPS 
Preliminary mass spectra data of lipid A from B. pseudomallei indicated the presence of 
impurities, which made interpretation of data difficult. Figure 4.1 shows the mass spectra 
of the crude and purified lipid A from B. pseudomallei. After purification, a good signal 
to noise ratio was achieved and this enabled the characterization of lipid A structure. The 
purity of LPS from B. pseudomallei and B. thailandensis was also monitored by taking 
the absorbance of the LPS at 260nm and 280nm with a spectrophotometer (Table 4.1). 
Crude LPS showed high levels of protein and nucleic acid content. Upon purification, the 
levels of protein and nucleic acid were significantly decreased.   
4.3.2 Comparison of LPS from B. pseudomallei and B. thailandensis in-vitro 
To investigate if LPS from B. pseudomallei and B. thailandensis are recognized 
differently by host cells, RAW 264.7 were stimulated with increasing concentrations of 
LPS from the two organisms. When stimulated with crude LPS from B. pseudomallei and 
B. thailandensis, no significant difference (p>0.05) was detected in the levels of TNF-
produced (Figure 4.2). However, RAW 264.7 produced significantly higher levels of 
TNF- , IL-6 and IL-10 (p<0.05) when stimulated with purified LPS from 
B. thailandensis than from B. pseudomallei (Figure 4.3). On average, purified LPS from 
B. pseudomallei was approximately two times less potent in inducing cytokines 
production in RAW 264.7 than purified B. thailandensis LPS. LPS from E.coli, a potent 
stimulator of cells, was used as a positive control and was found to induce significantly
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Figure 4.1: Representative ESI/QTOF mass spectra of lipid A extracted from crude 
and purified LPS of B. pseudomallei. Data illustrates singly charged ions (A) and 
doubly charged ions (B) from crude LPS, and doubly charged ions (C) from purified LPS 
of B. pseudomallei.  
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Table 4.1: Comparison of nucleic acid (260nm) and protein (280nm) content of 
crude and purified LPS from B. pseudomallei and B. thailandensis.   
B. pseudomallei B. thailandensis Absorbance 
wavelength Crude Purified Crude Purified 
260nm 2.933 0.034 2.895 0.482 
280nm >3 0.058 >3 0.396 
          

















Figure 4.2: TNF- production in RAW 264.7 stimulated with crude LPS from 
B. pseudomallei (BP) and B. thailandensis (BT).  Data represent the means ± standard 
errors of the means from triplicate samples. Results shown are representative of 2 














































































Figure 4.3: TNF- production in RAW 264.7 stimulated with purified LPS from 
B. pseudomallei (BP) and B. thailandensis (BT).  The cell culture supernatant was 
measured for TNF- (A), IL-6 (B) and IL-10 (C). EC represents LPS from E. coli. Data 
represent the means ± standard errors of the means from triplicate samples. Results 
shown are representative of 2 independent experiments. * indicates significant 





higher levels of cytokines than B. pseudomallei and B. thailandensis LPS.  
4.3.3 Structural analysis of lipid A from B. pseudomallei and B. thailandensis  
The lipid A from B. pseudomallei and B. thailandensis were subjected to a combination 
of mass-spectrometric analysis to investigate their structures (Figure 4.4). The negative 
ion ESI-QTOF mass spectra of purified lipid A from B. pseudomallei showed a 
heterogeneous mixture of doubly charged ions at m/z 973.59 and 965.53 (Figure 4.4a). 
Minor peaks of doubly charged ions at m/z 908.05 and 900.09 (not labeled) were detected 
as well. The mass differences of 131 units observed between doubly charged ions at m/z 
965.53 and 900.09, and between ions at m/z 973.59 and 908.05, indicated a likely 
difference of 4-amino-4-deoxy-arabinose (Ara4N) residue. The doubly charged ion at 
m/z 973.59 contained one more hydroxyl (-OH) group than the doubly charged ion at 
m/z 965.53.   Based on the accurate masses of the doubly charged species, the ions at 
m/z 973.59, 965.53, 908.05, and 900.09, were assigned to lipid A with molecular 
formulae of C96H182N4O31P2, C96H182N4O30P2, C91H173N3O28P2 and C91H173N3O27P2, 
respectively.    
The negative ion ESI-TOF mass spectra of purified lipid A from B. thailandensis showed 
major doubly charged ions at m/z 965.53, 900.09 852.59 and 787.01 and a minor doubly 
charged ion at m/z 834.50 (not labeled) (Figure 4.4b). The doubly charged ions at m/z 
973.59 and 908.05 detected in B. pseudomallei were not detected in B. thailandensis. 
Similar to the lipid A species in B. pseudomallei, the mass differences of 131 units 
observed between doubly-charged ions at m/z 965.53 and 900.09 indicated a difference of 
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Ara4N. The mass differences of 226 units between doubly charged ions at m/z 965.53 
and 852.59, or between ions at m/z 900.09 and 787.01, was attributed to a difference of 
one fatty acid, 3-hydroxy-tetradecanoic acid [C14:0(3-OH)]. Based on the accurate 
masses of the doubly charged species, the ions at m/z 965.53, 900.09, 852.59, 834.50 and 
787.01, were assigned to lipid A with molecular formulae of C96H182N4O30P2, 
C91H173N3O27P2, C82H156N4O28P2, C86H164N2O24P2 and C77H147N3O25P2, respectively.  
The major lipid A peaks identified in the ESI-QTOF mass spectra (965.53, 900.09, 
852.59 and 787.01) were further subjected to tandem mass spectrometry (Figure 4.5). The 
MS/MS fragmentation spectrum of lipid A species  at m/z 965.53 showed doubly charged 
daughter ion at m/z 900.07 ( m/z=131) (Figure 4.5a). This indicates a loss of Ara4N 
from the doubly charged parental ion at m/z 965.53 (fragment II, Figure 4.5a).  Similarly, 
the loss of phosphorylated Ara4N (fragment III, Figure 4.5a-d) was also observed among 
parental ions at m/z 965.53, 900.09, 852.59, and 787.01 (Figure 4.5a-d).  The fragmented 
ion at m/z 210.21 (Fig. 4.5a) indicates the loss of one water molecule from 
phosphorylated Ara4N (fragment I, Figure 4.5a). These results indicate that the Ara4N is 
attached to a phosphate group in the lipid A backbone.   
The sequential loss of C14:0(3-OH) ( m/z=226) from the doubly charged parental ion at 
m/z 965.53 to doubly charged daughter ions at m/z 852.48 and 739.5 (not labeled) were 
observed (Figure 4.5a). Furthermore, the doubly charged daughter ions at m/z 787.06 and 
673.93 arose from the sequential loss of C14:0(3-OH) from the doubly charged parental 
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on at m/z 900.09 (Fig. 4.5b). These results imply that C14:0(3-OH) is the major acyl 
chain attached to the disaccharide backbone.   
By combining the structural data from fatty acid compositional and mass spectrometry 
analysis, we have proposed the structure for the major lipid A fraction present in both 
B. pseudomallei and B. thailandensis at m/z 965.53 (Figure 4.6b). This lipid A consists of 
a bi-phosphorylated disaccharide backbone modified with Ara4N at both phosphate 
groups and penta-acylated with C14:0(3-OH), tetradecanoic acid (C14:0) and 3-hydroxy-
hexadecanoic acid [C16:0(3-OH)]. The lipid A fraction with doubly charged ion at m/z 
973.59 present only in B. pseudomallei is proposed to have the same structure as the ion 
at m/z 965.53 but with the hydroxylation of C14:0 to 2-hydroxy-tetradecanoic acid 
[C14:0(2-OH)] (Figure 4.6a). Similarly, lipid A with m/z at 900.09 was assigned to be a 
penta-acylated lipid A, but containing only one Ara4N group; lipid A with m/z at 852.59 
was assigned to be a tetra-acylated lipid A, containing two Ara4N groups; lipid A with 
m/z at 787.01 was assigned to be a tetra-acylated lipid A, containing one Ara4N group; 
and lipid A with m/z at 834.50 was assigned to be a penta-acylated lipid A containing no 
Ara4N group.  
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Figure 4.4: ESI-QTOF mass spectra of lipid A from B. pseudomallei and 
B. thailandensis obtained in the negative ion mode. (A) Mass spectrum of 
B. pseudomallei shows major doubly charged ions (z=2) of lipid A species at m/z 973.59 
and 965.53. (B) Mass spectrum of B. thailandensis shows doubly charged ions (z=2) of 
lipid A species at m/z 965.53, 900.09, 852.59, 834.50 (not labeled) and 787.01.   
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Figure 4.5: ESI/MSMS mass spectra of the major lipid A species. MSMS of doubly 
charged ions (z=2) at m/z 965.53(A), 900.09 (B), 852.59 (C) and 787.01 (D). [I] indicates 
the loss of one water molecule from phosphorylated Ara4N, [II] indicates the loss of 
Ara4N from the doubly charged parental ion and [III] indicates singly charged parental 
ions with loss of phosphorylated Ara4N.  
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Figure 4.6: Proposed structures of the major lipid A species present in 
B. pseudomallei and B. thailandensis. (A) Proposed structure of lipid A species at 
m/z 973.59 present only in B. pseudomallei; (B) Proposed structure of lipid A species at 
m/z 965.53 present in both B. pseudomallei and B. thailandensis. Arrow indicates the 
unique presence of C14:0(2-OH) in the lipid A of B. pseudomallei only. Substitution of 
fatty acids to the lipid A backbone is in no particular order. [I] indicates the loss of one 
water molecule from phosphorylated Ara4N, [II] indicated the loss of Ara4N from the 






















































































4.4 DISCUSSION  
The endotoxic activity of lipid A varies strongly with its primary structure, namely the 
fatty acids and polar heads that make it up (Seydel et al., 2000). The finding in chapter 3 
that the LPS fatty acid composition was different between B. pseudomallei and 
B. thailandensis prompted our investigations into the biological and structural differences 
in these two pathogens. B. thailandensis is a close relative of B. pseudomallei and 
co-exists with B. pseudomallei in the soil. However, B. thailandensis rarely causes 
disease and is more than 105 fold less virulent than B. pseudomallei in Syrian Hamsters or 
mice (Brett et al., 1998). Hence, the difference in LPS fatty acid composition observed 
between B. pseudomallei and B. thailandensis may contribute towards the different 
pathogenesis observed.   
Initial stimulation assays showed that LPS from B. pseudomallei and B. thailandensis 
activated murine macrophages similarly, despite the difference observed in the fatty acid 
composition. This suggested that LPS may not play an important role in the virulence of 
B. pseudomallei since no difference was observed in the host recognition of LPS from 
B. pseudomallei and B. thailandensis. However, mass-spectrometry analysis revealed that 
the LPS of B. pseudomallei was associated with contaminating sugars and proteins, 
which made structural interpretation challenging. Hence, the observed similarity in 
recognition of LPS from the two species may have arisen as an artifact of contaminants 
present in the LPS. This prompted the search for a suitable method to purify the LPS. 
Upon purification, it was found that murine macrophages (RAW 264.7) produced two 
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times more cytokines in response to purified LPS from B. thailandensis than to purified 
LPS from B. pseudomallei. Structural analysis further revealed that the major lipid A 
species in B. pseudomallei consisted of a bi-phosphorylated disaccharide backbone 
modified with Ara4N at both phosphate groups and penta-acylated with C14:0(3-OH), 
C16:0(3-OH) and either C14:0 or C14:0(2-OH). On the contrary, the major lipid A 
species identified in B. thailandensis was a heterogenous mixture of penta- and tetra-
acylated structures varying in Ara4N substitution and acylation of C14:0(3-OH). The 
substitution of C14:0(2-OH) to the lipid A backbone was unique to B. pseudomallei and 
not found in B. thailandensis.   
Lipid A is the endotoxic and bioactive centre of LPS (Miller et al., 2005). Some 
Gram-negative bacteria have evolved to modify the structure of their lipid A in order to 
evade anti-bacterial mechanisms initiated by the host innate immune system (Montminy 
et al., 2006). One such modification is the synthesis of LPS with low biological activities. 
For example, the hexa-acylated lipid A of E. coli represents the most biologically active 
form of the molecule (Caroff et al., 2003). However, when E. coli was genetically 
modified to express penta-acylated lipid A, it showed reduced immunogenicity and acted 
antagonistically by inhibiting pro-inflammatory signaling induced by wild-type E. coli 
and LPS from other bacteria (Backhed et al., 2003).  The LPS of B. pseudomallei has 
been previously shown by other groups to stimulate host cells weakly compared to E. coli 
LPS in-vitro (Matsuura et al., 1996; Utaisincharoen et al., 2001). Similarly, we found that 
although purified, LPS from B. pseudomallei induced low levels of cytokines from 
murine macrophages in-vitro. The ability of LPS from B. pseudomallei and 
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B. thailandensis to activate murine macrophages weakly compared to E.coli LPS may be 
attributed to their penta-acylated structures, which are substituted with longer fatty acids 
[C14:0(3-OH) and C16:0(3-OH)] than E.coli LPS. Differences in the relative amounts of 
individual lipid A species and the existence of lipid A species acylated with C14:0(2-OH) 
only in B. pseudomallei may contribute to the differential recognition of B. pseudomallei 
LPS compared to B. thailandensis LPS by murine macrophages in-vitro.  
The lipid A of Burkholderia mallei consist of a mixture of tetra- and penta-acylated lipid 
A structures substituted with C14:0, C14:0 (3-OH) and C16:0 (3-OH) (Brett et al., 2007). 
Although its lipid A is similar to that of B. thailandensis, the LPS from B. mallei 
stimulates cells in a manner similar to E.coli LPS. The authors suggested that by 
optimizing the order its LPS fatty acids, B. mallei may produce LPS molecules with 
biological properties similar to the potent hexa-acylated species (Brett et al., 2007). As 
the order of fatty acid acylation was not determined in the study here, it is likely that that 
the differences in the immunological activities of LPS from B. pseudomallei and 
B. thailandensis compared to B. mallei may be contributed by differences in the order of 
fatty acyl chains to the lipid A backbone and the relative amounts of individual lipid A 
species. In addition, minor lipid A species differentially substituted with longer fatty 
acyls C16:0 and C18:0 were detected in the MS/MS spectra of B. pseudomallei and 
B. thailandensis. These lipid A species may further contribute to the lower 
immunological activities of these species in-vitro.   
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The phosphate groups of lipid A in some pathogenic bacteria are modified with Ara4N, 
allowing the bacteria to resist the bactericidal effects of endogenously produced host 
cationic antimicrobial peptides (CAMPS) (Gunn et al., 2001). The lipid A of Salmonella 
serovar Typhimurium becomes modified with Ara4N residues when grown under 
magnesium deficient conditions, which mimic the environment of a macrophage 
phagosome (Guo et al., 1997). This decreases the overall negative charge on the 
pathogen s cell surface and lowers the affinity for CAMPS (Kawsaki et al., 2005). In our 
structural analysis, the phosphate groups in the major lipid A species of B. pseudomallei 
were found to be capped with Ara4N residues. Modification with Ara4N may increase 
the resistance of B. pseudomallei to CAMPS and allow the bacterium to survive and 
replicate within host cells. Similarly, B. pseudomallei has been shown to be resistant to 
the cationic peptides protamine sulfate and purified human defensin HNP-1 in-vitro 
(Jones et al., 1996). On the contrary, in B. thailandensis, there were major lipid A species 
identified with only one phosphate group substituted with Ara4N. Minor lipid A species 
without Ara4N substitution were also present in B. thailandensis. This may contribute to 
the difference in pathogenesis observed between B. pseudomallei and B. thailandensis.   
In Salmonella serovar Typhimurium, hydroxylation of C14:0 to C14:0(2-OH) is observed 
in response to low magnesium concentrations in the host micro-environments. This has 
been postulated to confer resistance to cationic anti-microbial peptides (CAMPs), 
permitting a prolonged survival of the bacteria inside the host cell (Guo et al., 1997; 
Gibbons et al., 2000). Likewise, the hydroxylation of C14:0 to C14:0(2-OH) in 
B. pseudomallei may contribute to the pathogenesis by allowing the bacterium to subvert 
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host cellular responses and survive within host cells. Lipid A species acylated with 
C14:0(2-OH) was not found in B. thailandensis. The presence of C14:0(2-OH) in 
B. pseudomallei and not in B. thailandensis was similarly demonstrated in a study that 
compared the cellular fatty acid profiles of B. pseudomallei and B. thailandensis (Inglis et 
al., 2003).  
In conclusion, the ability of B. pseudomallei LPS to evade strong immune cell activation 
may be due to the unique structural features of its lipid A. The presence of longer acyl 
chains, C14:0(2-OH) and Ara4N capped phosphate groups may allow the bacterium to 
evade host recognition through weak activation of innate immune system and resistance 
to CAMPS. In addition, the differences in lipid A of B. pseudomallei and B. thailandensis 
may contribute to the observed differences in the ability to cause disease. 
   
Chapter 5   
Determination of the  
Toll-like receptor (TLR) involved in 
the recognition of LPS from  
B. pseudomallei and 
B. thailandensis  
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5.1 INTRODUCTION  
The recognition of bacteria as non-self agents by mammalian cells is an important innate 
response against infection. Innate immune responses to pathogens are mainly carried out 
by monocyte or macrophages, granulocytes and dendritic cells, which act as the first line 
of defence against invading micro-organisms (Medzhitov et al., 1997). Pattern 
recognition receptors on these immune cells are able to recognize micro-organism 
specific molecules that are essential and conserved. One such group of pattern 
recognition receptors is the family of Toll-like receptors (TLRs) (Medzhitov, 2001).   
TLRs can be divided into 2 distinct subpopulations, those that are on cell-surface and 
those that are found intracelluarly. Cell surface TLRs include TLR4/MD-2 that 
recognizes lipopolysaccharide (LPS), and TLR2/TLR1 and TLR2/TLR6 heterodimers 
that recognizes bacterial lipoproteins.   
LPS is a major component of the outer membrane of Gram-negative bacteria. 
Recognition of LPS by TLR4 depends on the structure of lipid A, the bioactive and 
endotoxic region of LPS (Miller et al., 2005). Some preliminary reports suggest that 
TLR2 may be able to recognize some LPS structures (Braedel-Ruoff et al., 2005; 
Hirschfeld et al., 2001); however others have shown that this is an artifact caused by the 
presence of contaminating lipoproteins in the LPS preparation (Lee et al., 2002).  
In this chapter, since we have managed to obtain purified LPS fractions, we aim to 
identify the TLR that is involved in recognizing the LPS from B. pseudomallei and 
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B. thailandensis. HEK 293, a human embryonic kidney cell-line does not have 
endogenous TLRs (Hornung et al., 2002), and was thus chosen to study TLR-dependent 
activation of cells. This was achieved by transfection to over-express either TLR2 or 
TLR4 in these cells. Binding of specific ligands to specific TLRs initiates a complex 
signal transduction cascade, ultimately leading to the activation of nuclear factor kappa 
beta (NF- ), which then induces the transcription of a plethora of inflammatory 
cytokines and chemokines (Miller et al., 2005). Hence NF- was chosen to quantify the 
activation of HEK 293 cells in the assays here.   
Like previous reports (Wiersinga et al., 2007), preliminary experiments in our laboratory 
indicated that B. pseudomallei LPS signals through TLR2. Given the possibility that 
lipoprotein contamination may complicate such experiments, we investigated if further 
purification of the LPS to remove contaminating proteins would change the recognition 
receptor to TLR4.          
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5.2 MATERIALS AND METHOD  
5.2.1  In-vitro culture 
HEK 293 cell-lines, transfected with either the human TLR2 or the human TLR4-MD2-
CD14 complex were purchased from InvivoGen (San Diego, CA). The complete medium 
used to maintain the cell-lines was DMEM containing 4.5g/l glucose, and 10% fetal calf 
serum with 10µg/ml of blasticidin and 50µg/ml of hydrogold. Untransfected HEK 293 
cells not expressing any TLR was also purchased from InvivoGen and used as a negative 
control.  
5.2.2  Flow cytometry  
Cells were harvested and washed twice in FACS (fluorescent-activated cell sorting) 
staining buffer (sterile PBS containing 1% fetal calf serum). A cell count was performed 
and cells were reconstituted to a concentration of 5 x 106 cells/ml. 200µl was added to 
FACS tubes and the relevant fluorescent tagged antibodies or their isotypes were added 
to each tube at the pre-determined concentration. The antibodies used were human TLR4, 
human TLR2 and human CD14. The cells were incubated with the antibodies on ice for 
30 minutes. After incubation, the cells were washed twice to remove unbound antibodies 
and reconstituted in 200µl of staining buffer. Data was acquired on a Becton Dickinson 
FACS Calibur using the CellQuest software (Becton Dickinson).    
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5.2.3 Plasmid preparation 
Plasmid (pNifty2) encoding NF- directed luciferase expression was purchased from 
InvivoGen. pNifty2 plasmid was provided as lyophilized transformed Escherichia coli. 
1ml of LB medium was added to re-suspend the lyophilized E.coli transformed cells. 
After mixing gently by inverting the tube several times, the bacteria were streaked out 
from the suspension to LB agar plates containing zeocin for the selection of transformed 
cells. The plate was placed into an incubator overnight at 37oC. The next day, a single 
colony was picked, and the bacteria were grown in terrific broth (TB) supplemented with 
zeocin for 14 hours at 37oC. The pNifty2 plasmid DNA was then extracted from the 
transformed E. coli using the QIAprep spin miniprep kit (Qiagen, Singapore) according 
to manufacturer s instructions.   
5.2.4 Site directed mutagenesis 
As a plasmid similar to pNifty2 but without NF- binding sites was not available from 
InvivoGen, site directed mutagenesis was carried out on the pNifty2 plasmid to obtain an 
empty vector plasmid, which would serve as a control to demonstrate that the induction 
of luciferase was specific to NF- .   
pNifty2 contains a Not1 restriction site at one end of the NF- binding site. Another 
Not1 restriction site had to be added to the other end of the NF- site to effectively 
excise this section. Primers encoding a Not1 restriction site and the corresponding 
flanking sequence of pNifty2 plasmid where the restriction site was to be inserted were 
synthesized from 1st Base (Singapore). The Not1 restriction site was inserted into pNifty2 
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using Quikchange mutagenesis kit (Stratagene, La Jolla, CA) according to manufacturer s 
instructions. After transforming XL10 Gold Ultracomp competent cells with the mutated 
plasmid, transformed cells were plated onto zeocin coated LB plates, and incubated at 
37oC overnight, following which about 10 colonies were picked and inoculated into TB 
supplemented with zeocin. The cultures were grown overnight and miniprep was 
performed as described. Glycerol stocks were prepared for the 10 colonies. Plasmid DNA 
extracted was then subjected to Not1 restriction and an analytical DNA gel was run to 
check for the presence of inserted gene. If the gene is inserted correctly, an additional 
450 base-pair (bp) fragment should be present compared to unrestricted samples. This 
450 bp corresponds to the section of the plasmid that encodes for the NF- binding site.  
After identifying the plasmid that contains the inserted gene, a preparative DNA gel was 
run using 800ng of the plasmid restricted with Not1. The high molecular weight band 
was excised and DNA was extracted using the QIAquick Gel extraction kit (Qiagen). The 
plasmid DNA was transformed into TOP10 competent cells and the cells were plated 
onto zeocin coated LB plates overnight. 10 colonies was chosen and inoculated into TB 
supplemented with zeocin and grown overnight. The next day, glycerol stocks were 
prepared and the miniprep was performed to extract the plasmid DNA. An analytical gel 
was run to check the absence of Not1 restriction site on the plasmid. This plasmid DNA 
corresponds to a vector similar to pNifty but without the NF- binding site, and was 
used as a control plasmid.   
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5.2.5 Transfection  
pGL4.74 [hRluc/TK] that encodes renilla luciferase expression constitutively and pSV- -
Galactosidase, a reporter vector that expresses -galactosidase constitutively were 
purchased from Promega (Singapore). Both vectors were used as control plasmids to 
normalize the transfection. As -galactosidase activity could not be detected in our 
system, renilla luciferase (pRen) was used as the control plasmid for all subsequent 
experiments.   
2 x 104 of HEK 293 cells were seeded per well of a 96 well plate. Cells were allowed to 
adhere overnight before proceeding with the transfection. Fugene 6 (Roche, Singapore) 
was brought to room temperature and mixed by inversion gently. For one sample to be 
transfected, 0.15µl of Fugene 6 reagent was added to 4.6µl of serum free medium 
(DMEM) in a sterile tube without touching the sides of the tube. The mixture was 
vortexed for 1 second and allowed to incubate at room temperature for 10 minutes. 0.2µl 
of pNifty2 or the mutated pNifty2, and 0.05µl of pRen were added to the diluted Fugene 
6 (ratio of Fugene 6 to DNA = 6:1). The transfection complex was allowed to incubate at 
room temperature for 30 minutes and 5µl of the transfection complex was added to the 
cells in a drop wise manner. The plates were swirled to ensure equal distribution of 
complex to the entire surface of cells. The cells were returned to the incubator for 24 
hours before proceeding with the cell stimulation.     
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5.2.6 Cell stimulation assay 
Phorbol 12-myristate 13-acetate (PMA), purified E.coli LPS that activates only TLR4 
and not TLR2, and purified lipoteichoic acid (LTA) that activates TLR2 were purchased 
from InvivoGen. LPS extracted using the hot phenol-water method from B. pseudomallei 
wildtype and capsular mutant strain K96243 was obtained as a gift from Dr. Joann Prior 
from the Defence Science and Technology Laboratory (United Kingdom).    
24 hours after transfection, cells were stimulated with PMA, LTA or LPS from E.coli, 
Salmonella enetrica serovar Typhimurium (Sigma), B. thailandensis strain 
ATCC 700388, and B. pseudomallei strains BP22 and K96243. The final concentration 
used was 100ng/ml for PMA and 1000ng/ml for LTA and LPS. Control cells were 
stimulated with medium only. Cells were allowed to incubate with the agonists for 7 
hours for the NF- activation assay and 18 hours for the IL-8 assay.   
5.2.7 NF- luciferase assay 
Dual-lucifease reporter assay system (Promega) was used to quantify NF- activation. 
Cell culture supernatant was removed, and the cells were washed twice with sterile PBS. 
30µl of 1x passive lysis buffer was then added to the cells, and the cells were allowed to 
lyse for 15 minutes on a shaking platform. After lysis, 20µl of the cell lysate was 
transferred to white luminescence plates and placed into a dual auto-injector luminometer 
platform (GloMax, Promega). The injector was programmed to add the reagents in 
sequential order and take the reading before moving to the next well. Relative light units 
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were obtained by normalizing the firefly luciferase value (pNifty or mutated pNifty) to 
the Renilla Luciferase value (pRen).   
5.2.8 IL-8 analysis 
After 18 hours of incubation with the various ligands, the cell culture supernatant was 
analyzed for the expression of IL-8 by ELISA (Cytometric Bead Assay, BD 
Pharmingen).   
5.2.9 Statistical analysis 
All results were analysed by unpaired Student s t test using 2-tailed distribution. 
Differences with p<0.05 was considered significant.              
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5.3 RESULTS  
5.3.1 Distribution of receptors on cells 
To confirm the cellular responsiveness of HEK 293 to the different TLR ligands, we 
examined the cell surface expression of TLR2, TLR4 and CD14 in untransfected HEK 
293 cells, TLR2 transfected HEK 293 cells and TLR4-CD14-MD2 transfected HEK 293 
cells (Figure 5.1). Untransfected HEK 293 cells did not express TLR2, TLR4 or CD14 
(Figure 5.1a). TLR2 transfected HEK 293 cells expressed only TLR2 (Figure 5.1b). 
Expression of CD14 and TLR4 was not detected in these cells.   
In HEK 293 cells that were transfected with the TLR4-CD14-MD2 complex, both TLR4 
and CD14 expression was detected (Figure 5.1c). TLR2 was not detected in these cells. A 
small proportion of cells not expressing any of the markers was also detected in the TLR4 
transfected cells.   
5.3.2 Specificity of TLR for its ligands 
To check the specificity of TLR2 and TLR4 in recognizing its particular ligand, TLR 
transfected HEK 293 cells were stimulated with various ligands (PMA, LTA or 
E.coli LPS). For a read-out of NF- activity, cells were additionally transfected with a 
NF- inducible reporter (luciferase) plasmid (pNifty). Renilla luciferase was used as a 
control to normalize the transfection. Figure 5.2 shows the results of the control 
experiment. PMA is direct stimulator of protein kinase C and hence is able to induce 
NF- activation regardless of the presence of TLRs. In line with this, PMA was able to
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Figure 5.1: Distribution of TLR2, TLR4 and CD14 in transfected and untransfected 
HEK 293. The cell surface expressions of TLR2, TLR4 and CD14 in untransfected (A) 
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Figure 5.2: Stimulation of HEK 293 cells with various ligands. Untransfected (A), and 
TLR2 (B) or TLR4-CD14-MD2 complex (C) transfected HEK 293 cells were stimulated 
with phorbol 12-myristate 13-acetate (PMA), purified lipoteichoic acid (LTA), or 
purified E.coli LPS (LPS). Media indicates mock stimulated cells. Experiments were 
repeated twice and results represents the mean with error bars indicating the standard 
error (n=7). * indicate significant difference (p<0.05) between the ligand and mock 
stimulated cells. ! indicates no significant difference (p>0.05) in comparison to mock 





induce NF- activation in untransfected HEK 293 and in TLR2 and TLR4 transfected 
cell-lines. This stimulation was significant (p<0.05) compared to mock stimulated cells. 
LTA was used as a positive control for TLR2 transfected cells and negative control for 
TLR4 transfected cells. Likewise, LTA was able to induce NF- activation only in 
TLR2 transfected cells (p=9.1x10-6 compared to mock stimulated cells). Although it 
appears that LTA was able to induce NF- activity in TLR4 transfected cells, the 
activation was not significant compared to mock stimulated cells (p=0.06). Purified LPS 
from E.coli was used as a positive control for TLR4 transfected cells. LPS from E.coli 
was able to induce NF- activity only in TLR4 transfected cells (p=1x10-6). Empty 
vectors (reporter plasmids not containing the NF- binding sites) were used as a 
negative control and they did not respond to any of the ligands used. Although the basal 
level of the empty vector was slightly higher than the NF- plasmid, it remained 
constant throughout the assay.  
5.3.3 Effect of purity on the recognition of B. pseudomallei and B. thailandensis 
LPS by TLR2 and TLR4 
To determine whether LPS from B. pseudomallei and B. thailandensis is recognized by 
TLR2 or TLR4, HEK 293 cells were used. Figure 5.3 shows the results of the stimulation 
assay using LPS from B. pseudomallei strain BP22. BP22 LPS was unable to induce NF-
activation in untransfected cells. The crude LPS obtained directly from the kit was 
recognized by both TLR2 (p=0.01, compared to mock stimulated) and 
TLR4 (p=2.4x10-7). On the other hand, purified BP22 LPS was recognized only by TLR4 
(p=9.9x10-11, compared to mock stimulated). No significant difference was observed 
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between the recognition of crude and purified BP22 LPS in the TLR4 transfected cell-
lines.  
LPS from B. thailandensis could induce NF- activation only in TLR4 transfected cell-
lines regardless of the purity status (Figure 5.4). TLR4-dependent activation of NF-
was significant compared to mock stimulated cells when stimulated with crude LPS 
(p=2x10-6) and purified LPS (p=9.2x10-9).   
5.3.4 IL-8 production in response to various ligands 
As HEK 293 cells produce only IL-8, this precluded the examination of other cytokines 
and chemokines that are NF-  regulated (Fan et al., 2007). Hence, the stimulation of IL-
8 by HEK 293 was investigated in response to the various ligands and LPS (Figure 5.5). 
In untransfected cells, only PMA induced IL-8 production. In TLR2 transfected cells, 
only PMA and LTA induced IL-8 production. LPS from BP22 and B. thailandensis did 
not stimulate TLR2 regardless of purity status. All the LPS tested were able to induce 
IL-8 production by TLR4 transfected cells. Only LTA, the negative control could not 
stimulate IL-8 production in these cells.   
5.3.5 Effect of LPS extraction method on recognition by TLR2 and TLR4 
To investigate if the method of extraction affects the recognition of LPS by TLR2 or 
TLR4, LPS from B. pseudomallei strain K96243 was extracted using the hot phenol-
water method and compared to the kit extraction method (Figure 5.6).  K96243 LPS was 
unable to induce NF- activation in non-transfected cells. In TLR2 transfected cells, 
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Figure 5.3: Stimulation of HEK 293 cells with LPS from B. pseudomallei strain 
BP22. Untransfected (A), and TLR2 (B) or TLR4-CD14-MD2 complex (C) transfected 
HEK 293 cells were stimulated with either crude LPS (BP22) or purified LPS (BP22 
purified) from B. pseudomallei strain BP22. Media indicates mock stimulated cells. 
Experiments were repeated twice and results represents the mean with error bars 
indicating the standard error (n=7). * indicate significant difference (p<0.05) between the 
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Figure 5.4: Stimulation of HEK 293 cells with B. thailandensis LPS. Untransfected 
(A), and TLR2 (B) or TLR4-CD14-MD2 complex (C) transfected HEK 293 cells were 
stimulated with either crude LPS (BT) or purified LPS (BT purified) from 
B. thailandensis. Media indicates mock stimulated cells. Experiments were repeated 
twice and results represents the mean with error bars indicating the standard error (n=7). 


























































Figure 5.5: IL-8 production by HEK 293 cells stimulated with various ligands. 
Untransfected (A), and TLR2 (B) or TLR4-CD14-MD2 complex (C) transfected HEK 
293 cells were stimulated with phorbol 12-myristate 13-acetate (PMA), purified 
lipoteichoic acid (LTA), or LPS from E.coli (EC), Salmonella serovar Typhimurium 
(ST), B. pseudomallei (BP22) or B. thailandensis (BT). Media indicates mock stimulated 
cells. Experiments were repeated twice and results represents the mean with error bars 





LPS extracted by the hot aqueous phenol method (p=0.002, compared to mock 
stimulated) and kit (p=0.01) were able to induce NF- activity. However, the activation 
by the kit extracted LPS was 20 fold less than the LPS extracted by hot aqueous phenol 
method (p=0.002). Similar to the LPS from BP22, upon further purification, LPS 
extracted with the kit could not induce NF-   activation in the TLR2 transfected cells. In 
the TLR4 transfected cells, NF- activation was induced by both the LPS and this 
activation was significant compared to activation in mock stimulated cells (p < 0.05). No 
significance difference was observed in the LPS stimulation between the hot aqueous 
phenol extraction method and the kit extraction method in the TLR4 transfected cells.  
5.3.6. Effect of capsular polysaccharide on recognition by TLR2 and TLR4 
Finally, to investigate if the presence of capsular polysaccharide would contribute 
towards NF- activation, LPS extracted from a capsular mutant strain of K96243 was 
compared to LPS from the wild-type strain (Figure 5.7). LPS from the capsular mutant 
strain also did not induce NF- activation in the untransfected cells. Similar to the wild-
type strain, LPS from the capsular mutant strain was able to induce NF- activation in 
both TLR2 (p=1.5 x 10-5, compared to mock stimulated) and TLR4 (p=3.1 x 10-5) 
transfected cells. There was no significant difference in NF-  activation induced by LPS 
extracted from capsular mutant strain and wild-type strain (p>0.05) in TLR2 and TLR4 
transfected cells.    
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Figure 5.6: Comparison of LPS extraction method used on the stimulation of HEK 
293 cells. Untransfected (A), and TLR2 (B) or TLR4-CD14-MD2 complex (C) 
transfected HEK 293 cells were stimulated with LPS from B. pseudomallei strain 
K96243, extracted either by the hot phenol-water method (phenol) or the LPS extraction 
kit (kit). Kit extracted LPS that was purified further was also used as a ligand (kit + 
further purification). Media indicates mock stimulated cells. Experiments were repeated 
twice and results represents mean with error bars indicating the standard error (n=6). * 
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Figure 5.7: Effect of the presence of capsule on the stimulation of HEK 293 cells. 
Untransfected (HEK 293-null), and TLR2 (HEK 293-TLR2) or TLR4-CD14-MD2 
complex (HEK 293 TLR4) transfected HEK 293 cells were stimulated with LPS from 
B. pseudomallei strain K96243 wildtype or capsular mutant. Experiments were repeated 
twice and results represents mean with error bars indicating the standard error (n=6).           
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5.4 DISCUSSION  
Understanding the contribution of receptors involved in the innate recognition of LPS is 
essential in the context of potential therapeutic intervention. The LPS extracted from 
B. pseudomallei was able to stimulate cells via both TLR2 and TLR4. However, upon 
further purification to remove contaminants, signaling via TLR2 was abrogated, and the 
purified LPS was recognized only by TLR4. Our data indicates that TLR4 is the true 
receptor for the recognition of B. pseudomallei LPS.  
Two groups demonstrated the ability of TLR2 to signal in the response to LPS 
(Kirschning et al., 1998; Yang et al., 1998). Kirschning and group (1998) demonstrated 
that only overexpression of TLR2, but not TLR1, TLR4, or CD14 conferred LPS 
stimulation of NF- activation in mammalian HEK 293 cells, supporting the notion that 
TLR2 was the specific receptor for LPS (Kirschning et al., 1998). However, a genetic 
lesion identified in C3H/HeJ mice, which corresponded to a mutation in tlr4 gene 
(Poltorak et al., 1998), made the mice highly susceptible to Salmonella infection and 
resistant to its LPS, compared to C3H/HeN mice with intact response to LPS. This 
finding prompted the search for the true receptor of LPS and it was initially found that 
both TLR2 and TLR4 could respond to LPS (Chow et al., 1999). The failure of 
Kirschning and group (1998) to observe LPS inducible NF- activation of HEK 293 
cells transfected with TLR4 was attributed to inherent differences in stocks of HEK 293 
cells. Some stocks of HEK 293 cells could respond to LPS without any transfection 
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(Chow et al., 1999), emphasizing the importance in ascertaining the basal stimulation of 
untransfected cells by the ligands used.   
Hirschfeld and group (2000) demonstrated that the stimulation of TLR2 by LPS was due 
to lipoprotein contamination in LPS preparations (Hirschfeld et al., 2000). Similarly, the 
ability of Porphyromonas gingivalis LPS and its natural lipid A fraction to induce NF-
activation in Ba/F3 cells expressing mouse TLR2  was attributed to minor contaminants 
present. The purified contaminants induced NF- activation through TLR2 (Ogawa et 
al., 2007)   
A recent publication reported that TLR2 was the receptor involved in the recognition of 
LPS from B. pseudomallei (Wiersinga et al., 2007). On the contrary, Hii et al., (2008) 
showed that B. pseudomallei activates NF- through TLR4. Although their data was 
based on whole bacteria rather than purified LPS, activation of NF- through TLR4 
indirectly indicated recognition of B. pseudomallei LPS by TLR4. Supporting their data 
was a study by West and colleagues, who confirmed that B. pseudomallei LPS was a 
TLR4 agonist (West et al., 2008). Hence, the observations by Wiersinga et al., (2007) 
could be due to either the use of different strain of bacteria or the presence of 
contaminants in the extracted LPS that are strongly recognized by TLR2. In fact, the 
method of LPS extraction used may have contributed significantly to their observation. 
The LPS used in their studies were extracted by the modified hot phenol-water method, 
the established procedure for the extraction of LPS from B. pseudomallei (Perry et al., 
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1995). As LPS from B. pseudomallei partitions into both the phenol and water phase, this 
LPS was subsequently recovered from both phases (Perry et al., 1995).   
To investigate whether the method of extraction used may influence the TLR recognition 
of LPS, we compared NF- activation in TLR2 or TLR4 transfected cells using LPS 
(B. pseudomallei strain K96243) that was extracted by the hot phenol-water method to 
the kit extraction method. LPS extracted by the classical hot phenol-water method was 
recognized by both TLR2 and TLR4 and the recognition by TLR2 was 20x more 
stimulatory than LPS extracted by the kit. However, when LPS extracted by the kit was 
purified to remove contaminants, signaling through TLR2 was abrogated. As LPS 
extracted using the hot phenol-water method was obtained as a gift, the amount was too 
little to undergo further purification. Consequently, we were unable to investigate if the 
removal of contaminants from this LPS preparation would abrogate signaling through 
TLR2.   
Several groups have shown that lipoproteins enter the phenol phase and purifying LPS 
from this phase results in LPS preparations that may be contaminated with lipoproteins 
(Tirsoaga et al., 2007). Over-expression of TLR in human or murine cell-lines makes 
them very sensitive to minute amounts of endotoxic proteins, thus pure preparations of 
LPS are prudent in such studies. It is likely the observation made that TLR2 was the 
recognition receptor for B. pseudomallei LPS was due to lipoproteins present in the 
preparation (Wiersinga et al., 2007).  In support, both the strains of LPS tested here 
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(K96243 and BP22) were recognized by only TLR4 after the contaminants had been 
removed.   
For B. thailandensis, TLR4 was found to be the receptor that recognizes its LPS. This is 
the first time a study has shown the receptor involved in the recognition of 
B. thailandensis LPS. Surprisingly, for this LPS, even the crude preparation before 
purification did not stimulate TLR2. While the reason for this has not been investigated 
in this study, we postulate that unlike in some bacteria where LPS is associated strongly 
with outer-membrane proteins, LPS is not so associated in B. thailandensis.  
When LPS of B. pseudomallei was compared to LPS of B. thailandensis, we found no 
significant difference in the recognition of these LPS by TLR4. However, these LPS were 
differently recognized by RAW 264.7 (Chapter 4). We also found that the potent LPS 
from Salmonella serovar Typhimurium and E. coli activated TLR4 transfected HEK 293 
cells similarly to LPS from B. pseudomallei and B. thailandensis.  It is likely that the 
amount of LPS used in these studies was at saturation point, and hence no difference in 
stimulation was observed among the different LPS. Further investigations will be needed 
to confirm this suggestion.  
LPS purified from B. pseudomallei is known to co-precipitate with capsular 
polysaccharide (Isshiki et al., 2001). To investigate if the presence of capsule, if any, 
would affect the recognition by TLR4, the activation of NF- was compared between 
LPS extracted from the wild type strain and a capsular mutant strain of K96243. No 
 106
difference was observed in the stimulation of TLR4 transfected HEK 293 cells by the two 
LPS. This suggests that capsule polysaccharide, if present, does not contribute to the 
observed activation of NF- .  
In-vivo data by Wiersinga and co-workers demonstrated that TLR4 knock-out mice had 
similar survival rates, bacterial loads and lung inflammation to the wild-type animals in 
experimental melioidosis (Wiersinga et al., 2007). Although they conclude that TLR4, 
and indirectly B. pseudomallei LPS play no role in the immune response in-vivo, their 
data further emphasizes our point that the reduced stimulatory potential of 
B. pseudomallei LPS plays an important role in the pathogenicity of B. pseudomallei by 
allowing it to evade the innate immune system.  
Identification of the TLR involved in the recognition of LPS may be important for 
therapeutic intervention. The data here indicates that the pathogenicity of B. pseudomallei 
is partly linked to its ability to evade host defenses as its LPS is poorly recognized by 
TLR4. Hence, the design of exogenous TLR4 ligands or agonists that boost the innate 
immune response to infection with B. pseudomallei and compensate for the reduced 
TLR4 stimulation may be beneficial in clearing the disease.  
      
Chapter 6  
Overall Conclusions 
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6.1 CONCLUSIONS  
PhoP-PhoQ is a two-component environmental regulatory system that governs virulence 
and mediates the adaptation to magnesium (Mg2+) limiting environments in several 
Gram-negative species (Groisman, 2001). The finding that a similar system may exist in 
B. pseudomallei prompted our investigations in the effect of magnesium on the virulence 
of B. pseudomallei.  Mg2+ has been described to regulate lipid A modifications in 
Salmonella enterica serovar Typhimurium and Pseudomonas aeruginosa. As preliminary 
experiments in our laboratory demonstrated that B. pseudomallei was more virulent when 
cultured in magnesium limiting culture medium, we hypothesized that the increase in 
virulence observed in response to low magnesium concentrations was a result of surface 
remodeling of lipid A in B. pseudomallei. However, when the fatty acid composition of 
lipopolysaccharide (LPS) extracted from B. pseudomallei cultured in magnesium 
supplemented medium was compared to that of bacteria cultured in low magnesium 
concentration medium, no qualitative differences were found. We further compared the 
ability of LPS extracted from the two different media to induce cytokine production in both 
murine and human macrophage cell-lines in-vitro. No difference was observed in the 
ability of B. pseudomallei LPS extracted from either medium to induce cytokine production 
in these cell-lines. Based on these findings, we concluded that magnesium does not play a 
role in the surface remodeling of B. pseudomallei  LPS.  
Burkholderia thailandensis is a close relative of B. pseudomallei. Although it shares the 
same ecological niche, it rarely causes disease (Glass et al., 2006; Smith et al., 1997). 
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Several groups have used B. thailandensis as a model system to identify virulence 
mechanisms in B. pseudomallei (Haraga et al., 2008). Similarly, we compared the LPS of 
B. pseudomallei to the LPS of B. thailandensis to understand the role of LPS in the 
pathogenesis of B. pseudomallei . Our experiments showed that the purity of LPS was very 
important when comparing biological activities. Although initial experiments showed no 
difference in the ability of LPS from B. pseudomallei and B. thailandensis to induce 
cytokine production in murine macrophage cells, upon further purification to remove 
contaminating proteins, B. thailandensis LPS induced higher production of cytokines than 
B. pseudomallei  LPS in-vitro. This difference correlated with the structure variability of 
lipid A between the two organisms.   
The major lipid A species identified in B. pseudomallei consisted of a bi-phosphorylated 
disaccharide backbone modified with 4-amino-4-deoxy-arabinose (Ara4N) at both 
phosphate groups and penta-acylated with C14:0(3-OH), C16:0(3-OH) and either C14:0 
or C14:0(2-OH). On the contrary, the major lipid A species identified in B. thailandensis 
was a heterogenous mixture of penta- and tetra-acylated structures varying in Ara4N 
substitution and acylation of C14:0(3-OH). In summary, two specific differences were 
found in the lipid A of the two pathogens. Firstly, the presence of C14:0(2-OH) was 
unique to B. pseudomallei and not found in B. thailandensis. Secondly, all the major 
species identified in B. pseudomallei had both phosphate groups modified with Ara4N. 
On the contrary, in B. thailandensis, there were major lipid A species identified with 
either no Ara4N modification or only one phosphate group modified with Ara4N. Based 
on these findings, and supporting evidence on the role of these structural features in other 
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Gram-negative bacteria, we postulate that the differences in structure may contribute to 
the variation in the virulence of B. pseudomallei and B. thailandensis. In B. pseudomallei, 
synthesis of lipid A with long fatty acyl chains and C14:0(2-OH) may contribute to the 
low immunological activities observed in-vitro. The presence of Ara4N modified 
phosphate groups and C14:0(2-OH) in its lipid A may further confer resistance to the 
effects of CAMPS.  Collectively, these modifications may allow B. pseudomallei to 
evade host recognition through weak activation of innate immune system and resistance 
to CAMPS, allowing the pathogen to survive intracellularly. On the contrary, the more 
potent LPS synthesized by B. thailandensis may activate the innate immune system more 
strongly. Consequently, B. thailandensis becomes more susceptible to the bactericidal 
effects of host innate immune responses, resulting in efficient clearance of the pathogen.   
Toll like receptor (TLR) 4 is the pattern recognition receptor of LPS (Miller et al., 2005). 
However, a recently published data indicated that TLR2, and not TLR4 was involved in 
the signal transduction of B. pseudomallei LPS (Wiersinga et al., 2007). As our initial 
experiments indicated the presence of contaminating proteins in B. pseudomallei LPS, we 
hypothesized that the presence of contaminating proteins were responsible for the 
signaling through TLR2. In accordance with this, we found that LPS extracted using the 
hot phenol-water method showed significant signaling through TLR2 and TLR4. 
However, when LPS was purified to remove contaminating proteins, signaling through 
TLR2 was eliminated and signaling was observed through TLR4 only. Similarly, purified 
B. thailandensis LPS stimulated host cells through TLR4. This study further emphasizes 
the need of pure preparations of LPS in biological assays. 
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6.2 FUTURE WORK  
In this study, the structures of lipid A from B. pseudomallei and B. thailandensis were 
proposed. To confirm the structures proposed here and to determine the order of fatty 
acids to the lipid A backbone, further structural analysis such as nuclear magnetic 
resonance (NMR) spectroscopy is required. Such analysis would give a clearer picture on 
the structure-function relationship of LPS in pathogenesis.  
The differences in the ability of B. pseudomallei LPS and B. thailandensis LPS to 
activate murine macrophages were observed in-vitro. In-vivo experiments need to be 
carried out to determine if the differences seen in cell culture will also be observed 
in-vivo. In addition, to confirm the postulations on the impact of structural differences on 
the virulence and intracellular survival of B. pseudomallei, it will be necessary to purify 
or synthesize individual lipid A species and observe their effects in-vitro and in-vivo.    
The studies here indicated that the pathogenicity of B. pseudomallei is linked to its ability 
to evade or suppress the activation of mammalian defenses as it gains access to and 
replicates in its intracellular niche. This is facilitated by a LPS structure that is poorly 
recognized by TLR4. Hence, the design of exogenous TLR4 ligands or agonists that 
boost the innate immune response to infection with B. pseudomallei and compensate for 
the reduced TLR4 stimulation may be beneficial in clearing the disease. The 
administration of such synthetic TLR4 agonists have been described to provide protection 
against experimental pneumonic tularemia in mice upon infection with Francisella 
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tularensis novicida, a Gram-negative bacterium with an unusual LPS structure that is also 
poorly recognized by TLR4 (Lembo et al., 2008).  
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Preparation of stocks and solutions 
1. N-minimal broth and agar 
1.1 Reagents used to prepare N-minimal media (prepared in laboratory) 
To make 1M KCl (Sigma), 100ml: 
Dissolve 7.46g in 100ml of distilled water 
To make 0.1M K2SO4 (Sigma), 100ml: 
Dissolve 1.74g in 100ml of distilled water 
To make 1M KH2PO4 (Merck), 100ml: 
Dissolve 13.61g in 100ml of distilled water 
To make 1M glucose (Sigma), 100ml: 
Dissolve 18.02g in 100ml of distilled water 
To make 1M MgSO4 (Sigma), 100ml: 
Dissolve 12.04g in 100ml of distilled water 
To make 0.1M MgSO4 (Sigma), 100ml: 
Dissolve 1.20g in 100ml of distilled water 
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To make 1.8mM FeSO4.7H20 (Sigma), 50ml: 
Dissolve 25.0mg in 50ml of distilled water (prepare fresh) 
To make 2mg/ml thiamine-HCl, 50ml: 
Dissolve 100mg in 50ml of distilled water (prepare fresh) 
1.2 To prepare N-minimal broth or agar, 1000ml: 
1g of Bacto-casamino acid 
17g Bactor agar (only used when making agar, not for broth medium) 
Dissolve in 865ml of distilled water and autoclave at 121oC for 20 minutes. Cool and 
maintain at ~50oC in a water bath. Add filter sterilized volumes of the following: 
5ml of 1M KCl  
5ml of 0.1M K2SO4 
1ml of 1M KH2PO4 
1ml of 1.8mM FeSO4 
1ml of 2mg/ml thiamine HCl  
100ml of 1M tris-HCl, pH 7.4 (1st Base, Singapore) 
22ml of 1M glucose 
For magnesium supplemented medium: 10ml of 1M MgSO4 
For low concentration magnesium medium: 80µl of 0.1M MgSO4 
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2.  Solubilisation buffer (whole cell profile) 
2.1 To prepare base buffer, 32ml: 
2ml of 1M tris-HCl, pH 6.8 (1st Base, Singapore) 
3.2ml of glycerol (Sigma) 
9.6ml of 10% SDS (prepared fresh) 
15.6ml of double distilled water 
Trace amount of bromophenol blue (Sigma) 
Add 50µl of -mercaptoethanol (55mM, Gibco) to 950µl of above base buffer, just 
before use. 
2.2 To prepare solubilisation buffer containing proteinase K, 32ml: 
Add 1mg of Proteinase K to 300 l of solubilisation buffer just before use. 
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3. Cell culture medium 
3.1 To prepare fetal calf serum (FCS): 
Heat-inactivate at 56oC for 30 minutes and aliquot into 50ml falcon-tubes. Store at -20oC. 
3.2 To prepare RAW 264.7 culture medium, 500ml: 
10ml of L-glutamine (200mM, Gibco) 
5ml of sodium pyruvate (100mM, Gibco) 
50ml of fetal calf serum 
Make up volume to 500ml with DMEM (Gibco) and filter sterilise.  
3.3 To prepare THP-1 culture medium, 500ml: 
5ml of L-glutamine (200mM, Gibco) 
5ml of sodium pyruvate (100mM, Gibco) 
5ml of HEPES (1M, Gibco) 
454 l of -mercaptoethanol (55mM, Gibco) 
50ml of fetal calf serum 
Make up volume to 500ml with RPMI (Gibco) and filter sterilise.  
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3.4 To prepare HEK 293 culture medium, 500ml: 
10ml of L-glutamine (200mM, Gibco) 
5ml of sodium pyruvate (100mM, Gibco) 
50ml of fetal calf serum 
Make up volume to 500ml with DMEM (Gibco) and filter sterilise.  
3.5 To prepare TLR2 or TLR4 transfected HEK 293 culture medium, 500ml: 
10ml of L-glutamine (200mM, Gibco) 
5ml of sodium pyruvate (100mM, Gibco) 
50ml of fetal calf serum 
500 l of blasticidine (10mg/ml, Invivogen) 
250 l of hydrogold (100mg/ml, Invivogen) 
Make up volume to 500ml with DMEM (Gibco) and filter sterilise.  
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4. LPS re-purification buffer 
To make repurification buffer, 500ml: 
0.055g of CaCl2 (Sigma) 
0.102g of MgCl2.6H20 (Sigma) 
Dissolve in 400ml of PBS and make up volume to 500ml with PBS. 
5. Lipid A isolation buffer 
5.1 To make 1% SDS in 10mM sodium acetate, pH 4.5, 100ml:  
0.082g of sodium acetate (Sigma) 
1g of SDS (Sigma) 
Dissolve in 100ml of double distilled water. Adjust pH to 4.5 using 1M HCl. 
5.2 To make acidified ethanol, 20.1ml: 
Add 100µl of 4M HCl to 20ml of 95% ethanol. 
